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ABSTRACT 
 
Developing nanoscale carriers for the delivery of therapeutics is an important topic of 
investigation in current biomedical research. As opposed to traditional drug delivery systems, 
nanoscale systems offer enhanced tissue and cell permeation in addition to reducing drug 
elimination from the body. Biological based therapeutics such as DNA and proteins are now 
widely employed in medical applications and research has focused on using nanoscale drug 
delivery systems to administer these more effectively. Current synthesis methods of nanoscale 
biotherapeutic carriers face significant challenges. Among these are creating carriers with: sizes 
between 10-200 nm, low polydispersity, and non-cytotoxic materials. In this thesis, a nanocarrier 
synthesis method that meets these criteria is demonstrated using enzymatic methods to create 
monodisperse carriers that are 100 nm or less in size from entirely non-synthetic components. In 
the past, enzymatic synthesis of carriers has been limited due to the sensitivity and specificity of 
enzyme reactions to the presence of certain functional groups, substrates, temperatures, and 
pH’s. In the following work, we use the enzyme laccase to serve as a catalyst for the growth of 
hydrogel nanoparticles. It is known that laccase has the ability to convert iron (II) cations to iron 
(III) cations. Additionally, the biologically derived polymer called alginate exhibits crosslinking 
in the presence of iron (III) to form an aqueous polymer gel matrix. Using these three 
components, alginate polymer, laccase enzyme, and iron (II) sulfate, nanoscale hydrogel carriers 
were synthesized. Furthermore, we found that the size and polydispersity of the particles could 
be controlled through limitation of the enzyme activity. Dynamic light scattering, UV-Visible 
spectroscopy, Small Angle Neutron Scattering, and Atomic force microscopy were used to 
characterize the particle’s size, dispersity, growth rate, and growth mechanism. Using 0.36 mM 
iron (II) sulfate, monodisperse particles with a radius of 40 nm were formed. Increasing iron 
concentration increased the size and speed of the formation of the particles which resulted in 
their aggregation after reaching 100 nm in size. Here we have achieved simple synthesis of 
biodegradable nanogel particles with a hydrodynamic radius of 100 nm and below whose size 
can be tuned and exhibits low polydispersity.  
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CHAPTER 1: INTRODUCTION 
 
1-1). Current Directions in Drug Delivery Systems. 
Development of drug delivery systems for medical applications is an important topic of 
research in today’s society. They are used in drug delivery to enhance the efficacy of 
administered therapeutics in the body. These delivery devices impart desirable characteristics to 
drugs such as extended release time1, specific tissue targeting2, stimulus induced release3, altered 
solubility4, and more. Furthermore, drug carriers allow the delivery of sensitive therapeutics, 
such as biomolecules, inside the body because they easily degrade quickly when freely 
administered to patients. However, most developed synthesis methods for biomolecule carriers 
contain certain manufacturing hurdles. The aim of this research is to construct and characterize 
an improved method for the synthesis of nanoscale drug carriers to contain biological 
therapeutics such as proteins, DNA, RNA, and enzymes. In order to understand the synthesis 
considerations and rational behind any design scheme, it is important to describe the limitations 
in current research and what makes a successful drug carrier.  
When designing an efficient drug carrier, there are certain aims that improve the efficacy 
of delivery devices. The first aim is to limit the size of the carrier so that it is between 10 and 200 
nanometers. Particles smaller than 10 nm are known to be rapidly cleared from the body via the 
renal system.5 However, particles larger than 200 nm have a greatly reduced efficiency at 
entering the cytosol of cells.6 Delivery vesicles in this size range typically exhibit desirable 
properties such as increased tissue/cell penetration, evasion of the immune system, and targeting 
to drug delivery sites.7,2 All of these characteristics allow higher percentages of intact 
therapeutics to reach the specific sites in the body upon which they enact to more effectively 
alter the health of the patient (Figure 1-1).  
Additionally, controlling the size of particles allows drugs to be used to target specific 
tissues in the body. Many authors have shown that particles of a certain size are selectively 
internalized by tumor tissues.2,8 For example, in a paper by Zhang et al., gold nanoparticles 
coated with polyethylene glycol of diameter of 20 nm showed higher uptake by tumor tissues 
than particles of 40 nm and 80 nm in size.9 Such targeting technology will improve future drug 
efficacy in patients and allow administration of lower amounts of therapeutic as smaller doses 
are more effective due to targeting technology. 
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Figure (1-1). Effect of size on uptake of poly(ethylene imine) (PEI) coated gold nanoparticles 
into ovarian CHO-K1 cells.10 
 
 
The uptake of drug particles into the cytosol of cells is thought to occur via endocytosis. 
This is a process that cells utilize to internalize substances that cannot pass through their 
semipermeable lipid membrane. Endocytosis occurs when the cell membrane wraps itself around 
the particle on the surface to enclose it within the membrane. This enclosed particle is pulled 
inward so that it is broken off from the membrane and drawn inside the cell where it is directed 
to an appropriate organelle.11 There are multiple types of endocyctosis that can be used to 
internalize particles: phagocytosis, caveolae-mediated endocytosis, macropinocytosis, and 
clathrin- and caveolae-independent endocytosis.12 Most articles do not delve into the specific 
type of endocytosis used to internalize particles since the process varies greatly depending on the 
size, identity, and other properties of the particles. Although the method through which drug 
particles are internalized is not consistent, experimental evidence is plentiful in regards to the 
effect of particle size on cell internalization. It is well known that the ideal particle size for cell 
entry lies between 10 and 200 nanometers for most cell types. Therefore, aiming to create a 
carrier of this size is ideal for optimal delivery of therapeutics inside cells of the body.  
 Besides the optimization of size for the improvement of nanocarrier efficiency, there are 
other properties that are beneficial for biological therapeutic delivery systems to exhibit. These 
include: low particle size dispersity, water solubility, synthesis without the use of harsh solvents, 
and slow drug release profiles. 
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 Low Particle Size Dispersity. When limiting the size of drug carriers to below 200 nm 
during synthesis, the problematic issue of high particle dispersity usually appears.13,14 This 
occurs at the nanoscale because growth is usually much harder to control as experimental 
parameters become more rigid. Therefore, minute variations in the experimental conditions will 
produce large changes in the resulting particle’s characteristics.15 This association causes 
problems in many synthesis methods where either size or polydispersity is well controlled, but 
not both.16,17,18 It is desirable that drug carriers are synthesized with both homogenous size and 
low particle size dispersity because it ensures that delivery of the drug cargo is uniform from all 
particles.19 If all carriers are of the proper size to enter cells, then there is a higher probability 
that the carriers deliver drugs more efficiently. Additionally, uniform particle sizes will ensure 
that the liberation of therapeutics from each carrier follows the same release pattern.19 The 
diffusion of particles through the carrier matrix and into the body will occur on the same time 
scale if particles are uniform. This allows physicians to more accurately predict the lifetime of an 
encapsulated drug in the body and increases safety of the developed therapeutic for clinical use. 
 
 Water Solubility. Hydrophilic composition of drug carriers has traditionally been 
viewed as undesirable for drug delivery since hydrophobic particles have extended 
release/breakdown times in the body. This property gives some insoluble drugs twice the lifetime 
of that of soluble therapeutics.20 However, water soluble carriers offer the advantage of 
decreased aggregation, higher cell permeability21, and non-toxic environments for the 
encapsulation of biological therapeutics.22 In fact, many hydrophobic drugs must be altered with 
the addition of hydrophilic moieties to prevent their toxicity in vivo.23 Hydrophilic properties 
allow carriers to remain more uniformly distributed in solution, to avoid toxicity due to particle 
aggregation within cells, and to degrade less of the encapsulated therapeutic.23 Furthermore, 
aqueous environments within the carriers will stabilize biological molecules such as DNA and 
proteins that are frequently used in biomedicine applications. All of these factors indicate that 
purely hydrophilic or hydrophobic drug carriers are not ideal and that an appropriate mixture of 
both properties will impart the best drug efficacy with minimal damage to biological 
components. 
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Synthesis without Harsh Solvents. Many methods by which nanoparticle drug carriers 
are made involve the use of harsh chemicals or synthesis conditions. Examples of these methods 
include: the use of radiation to initiate polymerization24, organic solvents25, and radical 
chemistry26. Minimizing the use of denaturing components allows for the encapsulation of 
biological therapeutics such as proteins, DNA, RNA, and enzymes. Typically, carriers designed 
to contain biological materials must be extensively purified before loading the drug to remove 
denaturing contaminants.27 This complicates and extends the synthesis time of carriers. 
Development of a water-based synthesis method for nanoparticle production is one way to avoid 
such contamination to ensure effective and simple bio-therapeutic encapsulation. An example of 
this was demonstrated by Wang et al. where a copolymer carrier was synthesized in water using 
self-assembly techniques to encapsulate DNA with high efficiency. They also did not require a 
purification step before loading the particles with therapeutic.28   
 
Slow Drug Release Profile. When drugs are delivered into the body, the rate and 
duration at which they are released is an important parameter of clinical concern. By slowing 
down the release of a drug, the time over which it remains active in the body is extended.29 This 
helps maintain consistent therapeutic levels in the blood and increases patient compliance as 
administration is less frequent. During carrier design, the functional groups on the exterior of the 
particle can be altered to slow down drug liberation. Functional group hydrophobicity, charge, 
and identity can all drug release profiles.30 For example, Akala et al. developed a copolymer that 
only degrades when the solution pH changes from acidic to neutral. The real life application of 
such a carrier system is to protect the therapeutic from degradation in the stomach and invoke 
release in the intestinal tract once pH returns to neutral.31 Other examples include: constructing 
carriers with an affinity for the drug molecule in order to slow release32, mixing slowly 
degrading polymers into the carrier matrix to increase mechanical strength33, and coating the 
exterior of particles with a slowly degrading material34. 
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1-2). Current Nanoscale Drug Delivery Systems. 
 
Among the nanoscale drug carrier systems that meet the size requirements for optimum 
delivery (between 10-200 nm), several types of materials and encapsulation strategies exist. The 
most well-known of these are: nanoparticle/nanocapsules, polymer-drug conjugates, liposomes, 
polymers/block copolymers, self-assembled systems, and nanogels.35 These systems are all 
outlined in Figure 1-2. This thesis however will focus only on the synthesis of nanogels and their 
optimization as drug carriers. Nanogels offer good biocompatibility with biological molecules 
due to their high water content and non-toxic synthesis and breakdown. Most other nanoscale 
carriers currently used in drug delivery applications are challenged in these aspects and/or have 
complex synthesis methods.  
 
Metal-based Nanoparticles and Organic Frameworks. Nanoscale carriers that are 
primarily composed of metallic components can be categorized into two types: nanoparticles and 
metal-organic frameworks (MOFs). Beyond the inclusion of metals in their structure, these 
carriers are very different. Metallic nanoparticles are simply nano-sized particles of metallic 
components. Their synthesis is well established and most particles can be made with controlled 
size, shape, and polydispersity.36 Drug delivery via nanoparticles typically occurs by attachment 
or adsorption of the therapeutic onto the exterior of the particle. For example, Brown et al. 
designed a gold nanoparticle drug carrier on which they tethered the anticancer drug oxaliplatin 
for delivery into tumor cells.37 Another synthesis by Bhumkar et al. was performed by reducing a 
gold solution with the biodegradable polymer chitosan to form gold nanoparticles coated with 
the polymer. The authors demonstrated loading of insulin onto the polymer coating via simple 
incubation. The polydispersity of the carriers was too wide as their size typically varied from 10-
40 nm, however delivery efficiency of insulin in vivo for mice was significantly improved using 
the particles.38 
Another type of metallic-based nano carrier called nanoMOFs are nanoscale frameworks 
composed of both organic and metal components. Whereas nanoparticles can only attach drugs 
to their surfaces, nanoMOFs can encapsulate drugs and due to their high porosity which allows 
considerable drug loading in their matrices.39 An example of drug encapsulation can be seen in a 
paper by He et al. where UiO-nanoMOFs (based on a zirconium oxygen species with 
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dicarboxylate linkages) were loaded with siRNA. NanoMOF particles had a low polydispersity 
and diameter of approximately 100 nm. A high loading efficiency of siRNA biotherapeutic was 
shown to occur by heavy adsorption of the ribonucleotide to the exterior of the particle.40 Unlike 
nanoparticles, nanoscale MOFs are a new technology and the optimization of size and 
polydispersity has not yet been extensively explored.39 Overall metallic nanoparticles and 
nanoMOFs can offer one or more valuable drug delivery properties such as well-defined size, 
low polydispersity, and high loading capacities. In vivo toxicity of nanoMOFs has been reported 
to be low in two studies41,42, but further safety investigations must be undertaken before such 
therapeutic carriers become widely used. Additionally, the safety of many metallic nanoparticles 
in vivo has been shown to be questionable in scientific literature.43 Jeng  
 
Polymer-Drug Conjugates. Polymer-drug conjugates are single polymer chains that 
have been covalently bonded to the therapeutic molecules themselves. Using polymers instead of 
nanoparticles is beneficial because the toxicity and biocompatibility of most polymers are 
known. In addition, there are quite a few naturally derived polymers available for synthesis that 
decompose into non-toxic derivatives. Polymer conjugates are very small since they are usually 
only composed of one polymer chain and one drug molecule.44 An example of a conjugate can 
be seen in a paper by Bailon et al. where they accomplished PEGylation of interferon protein. 
They initiated conjugation via pH adjustment of a succinimidyl functionalized PEG and purified 
the product multiple times on a column and then concentrated the product. They showed that 
enzyme activity was decreased to 7% from the initial protein, however the drug had an increase 
in efficacy in vivo which they explained was due to an increase in retention time.45 Their 
technology has been patented under the name PEGasys and is now used to treat patients with 
hepatitis C. Although no issues with this conjugate have arisen, other conjugate based carriers 
frequently exhibit issues such as immunogenicity.46 Additionally, the polydispersity of polymer 
drug conjugates is difficult to reduce since it is dependent on many factors such as the purity of 
the utilized polymer, number of polymers attached to the drug, the site of attachment, and purity 
of the isolated conjugate. Another consideration during synthesis is that conjugation of drugs 
typically attenuates or enhances their elimination in vivo. Therefore, many design schemes 
incorporate release mechanisms into the drug-polymer linkage.47 Despite these setbacks, new site 
specific attachment schemes that include activated release mechanisms are in development, 
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however many still require complex synthesis and purification steps due to the demands required 
for an efficient conjugate carrier.46 
 
Liposomes. Liposomes make excellent biocompatible and biodegradable drug carriers. 
They are composed of a self-assembled bilayer of lipids within which a hydrophilic drug resides 
in an aqueous environment. The lipid exterior of these particles is useful in drug delivery because 
it interacts with the lipid bilayer membrane of cells. This assists with uptake of the drug payload 
and its penetration into the cell cytosol.48 Synthesis of these carriers is usually achieved by 
simple micro-emulsion techniques.49 However, when trying to synthesize liposomes below 100 
nm, the process quickly becomes challenging and polydispersity of the resulting particles is 
usually very high.50 In addition, the mechanical strength of liposomes is low so that in vivo they 
release their drug payloads very quickly as they degrade. Therefore liposomes are hard to use for 
extended release applications unless they are chemically modified.51 
 
Polymers/block copolymers. Polymers and block copolymers are useful materials in 
the synthesis of nanoscale drug carriers. One benefit they offer is a plethora of different types of 
molecules to choose from which allows for a broad range of properties to be instilled in carriers 
in addition to biocompatibility. For example, polymers can selectively degrade or unfold based 
on the presence of a specific pH, temperature, solvent, pressure, etc.31 The degree of response of 
these molecules can also be finely tuned during synthesis by changing the functional groups on 
the molecules or chemically attaching different polymers together to form block co-polymers. 
Because of these widely variable properties, the encapsulation and control of drug release from 
polymer based carriers is quite refined. The main challenge when synthesizing polymer drug 
carriers is the synthesis of nanosized particles below 100 nm. Typically, radical polymerization 
is used to synthesize small polymer particles.52 However, this is carried out in very harsh 
environments with toxic solvents and reactive molecules. In order to make a biocompatible 
carrier that is safe for in vivo use, the resulting product must be extensively purified which can 
be a time intensive process. Additionally, polydispersity of nanosized polymer particles is 
difficult to control by traditional means. Specific techniques are usually employed to achieve 
monodisperse nanosized polymer particles. However, these techniques still have limitations that 
may reduce their efficiency or feasibility as drug carriers in biomedicine.52 
8 
 
Self-Assembled Systems. Self-assembled drug carriers consist of carrier molecules that 
form particles through innate attraction of carrier components. Typical building blocks include 
charged polymers53 and proteins54,55 which impart biocompatible and biodegradable properties to 
the carriers. The advantages of these types of systems are due to the very monodisperse and 
small sizes that arise from this technique. For instance, nanocarrier particles consisting of self-
assembled β-Lactoglobulin protein near 60 nm have been reported with low polydispersity 
values.56 However, synthesis methods usually cannot be tailored to give another particle size 
since the self-assembly process is not easily altered.57 In order to make carriers of a different 
size, it is typically required that an entirely new polymer or protein of a different identity or size 
is used. 
 
Nanogels. Nanogels are useful biological drug carriers composed of nanosized hydrogels. 
They will be the drug carrier of focus in this thesis due to their biocompatibility and simple 
synthesis. These carriers are made out of cross-linked polymers and have a very high water affinity. 
This allows them to swell in aqueous environments to accommodate or release therapeutics. 
Similar to other polymer based systems, nanogels are frequently made with biocompatible and 
biodegradable materials. Furthermore, the high water content in their matrixes creates a favorable 
environment for the encapsulation and stabilization of biological therapeutics.58 They are 
additionally useful because the degree of crosslinking in the polymer matrix can easily be 
manipulated which allows for precise control over porosity of the synthesized hydrogel drug 
carriers.59 Control over this parameter helps retard and control the release rate of therapeutics from 
the nanogels. Due to these favorable characteristics, nanogels will be the encapsulation material 
of focus in this thesis. Encapsulation of biological materials is best accomplished when activity 
and structure of the materials are preserved and protected until they reach their desired target in 
the body. Nanogels are a platform that offer this in a simple and effective manner.  
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Figure (1-2). Several types of popular drug delivery particles. Self-assembled particles are not 
shown.36 
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1-3). Nanogel Synthesis, Current Techniques and Materials. 
 
 Biocompatible nanogels and hydrogels can be synthesized with three primary techniques. 
This is by the use of chemical, physical, and enzymatic crosslinking methods. Chemically cross-
linked gels offer the advantage of stronger mechanical strength. This prevents their degradation in 
vivo and extends drug release time. However, when focusing on the encapsulation of biological 
therapeutics, chemical crosslinking is difficult to use without lengthy purifications steps due to the 
denaturing and harsh synthesis conditions. Physically cross-linked gels and enzymatic gels are 
useful in this regard because they are both biocompatible and biodegradable even though their 
mechanical strength is lower.60 Enzymatic crosslinking is furthermore unique because it can 
substitute for either chemical or physical crosslinking and does not involve the use of cytotoxic 
reactants. However, this method has not been widely used due to the specificity of enzymes to 
their substrates and their sensitivity to environmental conditions. 
 
 Chemical Crosslinking. The polymers in chemically crosslinked gels are cross-linked 
using chemical means to form a covalent bond between the matrix components.52 There are many 
methods by which this is typically accomplished. One is by regular radical polymerization. In a 
study by Edman et al., a hydrogel was made from dextran polymers cross-linked with 
bisacrylamide using emulsion polymerization in a mixture of chloroform and toluene. Although 
dextran is a biocompatible polymer, the resulting hydrogel had to be extensively purified before 
application to remove all of the remaining excess bisacrylamide, chloroform, and toluene in order 
to be considered biocompatible.61 Another type of chemical crosslinking can be achieved by 
exposure to radiation. This can be done using either heat or light as an initiator. Raemdonck et al. 
used this method to produce nanogels via inverse miniemulsion photopolymerization. They used 
a mixture of biocompatible dextran monomers, methacrylate monomers, and photoinitiator to 
create the nanogel matrix upon exposure to 365 nm wavelength light. Again, these gels had to be 
put through an intensive purification process in order to be used for siRNA loading.62 Another 
method by which nanogels are made is through click chemistry. Known for its ability to perform 
chemical reactions in aqueous environments, click chemistry is a good method to crosslink 
polymers to form biocompatible hydrogel drug carriers. An example of a click nanogel synthesis 
can be seen from Heller et al. (Figure 1-3) where they used biphosphate-functionalized dextran 
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cross-linked by copper alkyne-azide cycloaddition.63 Although a simple synthesis, in order to 
remove the copper contamination a multiple day purification protocol had to be followed. There 
are other types of click chemistry that are used to synthesize nanogels, however nearly all have 
contaminants, complex synthesis, or unfavorable side reactions with which to contend.64 
 
 
 
Figure (1-3). An example of chemical crosslinking to form nanogels with a click synthesis 
method published by Heller et al.63  
 
 
 Physical Crosslinking. When aiming for the encapsulation of biological therapeutics, a 
much more biocompatible choice is the use of physically cross-linked nanogels. These are created 
when polymers are cross-linked in a manner that is not covalent.52 Although the linkages are less 
sturdy and therefore degrade more quickly, physically cross-linked gels are very simple to make 
and typically require no purification steps before use. Additionally, synthesis can occur at room 
temperature, physiological pH, and in aqueous solution. Some attractive forces used to crosslink 
nanogels include hydrogen bonding, hydrophobic aggregation, stereocomplexation, and charge 
condensation.59 Gels physically crosslinked through hydrogen bonds demonstrate problems when 
used for delivery applications as the bonds are so weak that the gels dissolve in a matter of hours.59 
Hydrophobically aggregated gels are usually not appropriate for biotherapeutic delivery as the 
interior environment of the gel is hydrophobic which disrupts the organization of  many biological 
molecules.65 Stereocomplexation, which refers to the attraction between enantiomers, is also 
suboptimal due to the sensitivity of the complexed bonds to polymer identities and the dominant 
solvent.59 There are other types of reversible interactions that can be used to make gels, however, 
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they are not extensively used in literature and will thus not be discussed. For in vivo drug delivery 
purposes, charge condensation is a good biocompatible and simple option. 
Charge condensation is the simplest method of the listed physical crosslinking methods 
and thus the most widely used. Charge condensation occurs in solution when two oppositely 
charged molecules exhibit a strong enough attraction for each other to create a cross-linked matrix. 
This gelation process can occur between many types of molecules such as: polymers with opposite 
charges and polymers and ions with opposite charges (Figure 1-4).59 The novelty of synthesizing 
hydrogels with charge condensation comes from the simplicity of the synthesis method which 
usually only requires 2-3 steps and does not need any final purification before use. An example of 
a nanogel synthesized using this method comes from authors Papadimitriou et al. They used 
chitosan grafted poly(ethylene glycol) copolymers cross-linked with both poly(glutamic acid) and 
tripolyphosphate to encapsulate bovine serum albumin (BSA) protein and slow its release. They 
demonstrated an increase in the time at which 80% BSA is released from an initial 20 hours to 80 
hours in vitro with their system.66 
 
 
 
Figure (1-4). Physical crosslinking via ion-polymer charge condensation. Here calcium ions 
attract the negative oxygen atoms (black dots) on the polymer chain.67 
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Enzymatic Crosslinking. Currently this method is not widely used, however enzymatic 
crosslinking is a good way to link polymers for the creation of biological drug carriers. Enzymes 
can be used to both chemically and physically crosslink hydrogel components. They serve as 
biocompatible catalysts that work to activate specific groups on the molecules in the solution.68 
Several examples of bulk hydrogel formation systems are listed in a review paper by Teixeira et 
al. Some notable strategies include: crosslinking of casein with microbial transglutaminase for 
extended release of Vitamin B12,69 using Thermolysin enzyme to trigger reverse hydrolysis to 
crosslink proteins and N-(fluorenylmethoxycarbonyl),70 and hydrogel formation via crosslinking 
of poly(ethylene glycol) functionalized with specific domains that crosslink upon exposure to 
transglutaminase enzyme factor XIIIa for encapsulation/stabilization of mammalian cells.71 Due 
to the sensitivity of enzymes to environmental conditions that may inactivate them, such as 
hydrophobic solvents, pH, and temperature, enzyme catalyzed formation of nanogels has not yet 
been achieved to the best of our knowledge. This thesis will focus on the use of enzyme initiated 
crosslinking for the formation of nanogel drug delivery carriers. The system studied herein will 
show how these formerly limiting environmental parameters can be appropriately adjusted to 
regulate nanogel particle size and dispersity. 
 
 Nanogel Materials. There are many polymers that exhibit swelling in water and thus there 
are many materials from which nanogels can be synthesized. When developing a system for 
biological therapeutics, it is important that the carrier material be both biocompatible and 
biodegradable. Biocompatible materials are known to be neutral in regards to invoking cell death 
and are typically tested for disruption of cell, enzyme, and other biological processes. These are 
plentiful and are already widely used in current drug formulations. Biodegradable materials are 
less commonly used but still plentiful in literature. These are defined as materials that are able to 
degrade in common biological conditions. Some examples include polymers such as poly(lactic 
acid), poly(lactic-co-glycolic) acid, poly-ɛ-caprolactone, poly-alkyl-acyanoacrylate.72 
Furthermore, there are also polymers that are derived from biological sources in addition to being 
biocompatible and biodegradable. These non-synthetic polysaccharides are isolated from natural 
products and purified for industrial use.73 Some examples include hyaluronic acid (derived from 
animals), chitosan (from insects), dextran (from bacteria), and alginate (from seaweed).74 Of these, 
chitosan and alginate are unique because they will ionically crosslink upon exposure to certain 
14 
 
metal cations resulting in a very simple synthesis protocol.75 This thesis will focus on the use of 
alginate for the development of nanogel drug delivery carriers instead of chitosan due to its ability 
to crosslink with the specific cations used in our synthesis scheme.  
 
 
1-4). Hydrogel Nanoscaling Techniques.  
 
Hydrogels are old technology and their synthesis has been known since the early 
1960’s.76 However, nanogels are a more recent development, and their formulation has 
challenged researchers to find new routes through which to create such small hydrogel particles 
with low polydispersity for biological therapeutic encapsulation. In this thesis, the focus will 
revolve around nanogels created with an ionically crosslinked polymer and metal cation system. 
Typical synthesis methods through which these types of nanoscale biological therapeutic carriers 
are made include: microemulsion, nanomolding, microfluidics, and self-assembly. 
 
Microemulsion. Microemulsion systems work by using two solvent phases, one 
hydrophilic and the other hydrophobic, to create micro or nanogels. The solution is mechanically 
perturbed by some force such as stirring or sonication to break up the phases and create small 
aqueous bubbles in the hydrophobic solvent. This method is designed so that the gel polymers 
are soluble only in the aqueous phase and thus crosslinking of polymers only occurs within the 
aqueous bubbles. An example from literature can be seen in a paper published by Nesamony et 
al. in 2012. In this synthesis, alginate was ionically crosslinked with calcium chloride in a 
mixture of water and an oil called isopropyl myristate. Upon sonicating, particles with a mean 
diameter of 6.7 nm with a large size distribution were formed.77 However, in order to form such 
small particles, the use of a surfactant was required. Surfactants are typically used in 
microemulsion synthesis techniques but must be removed before drug loading, which introduces 
a purification step. Although the synthesis used by Nesamony et al. was very simple and quick, 
purification was still necessary and the size distribution of the resulting particles sub-optimal for 
good drug delivery devices. 
  
15 
 
Nanomolding. Nanomolding is a technique that uses a template formed with 
photolithography technology to create gels of uniform size and shape. Polymer solution is laid on 
an adhesive layer and non-wetting molds pressed into the solution. Afterwards polymerization is 
initiated by various means and the mold withdrawn so that the particles remain on the adhesive. 
The sticky layer is then dissolved with solvent to free the particles and afterwards they are 
purified back into aqueous solution (Figure 1-5).78 This technique is quite complex to implement, 
but it offers the advantage of producing very precisely shaped and sized nanoparticles in large 
quantities. In a paper by Rolland et al. the synthesis of monodisperse 200 nm trapezoidal shaped 
nanogels made of poly(ethylene glycol) was demonstrated using photopolymerization and 
nanomolding techniques for the encapsulation of fluorescent avidin proteins. Confirmation of 
protein activity with confocal microscopy was accomplished via the submersion of the particles 
in a fluorescently labeled biotin solution. It was shown that encapsulation during the molding 
process did not alter the function of avidin since colocalization of the two fluorescence signals 
occurred.78  
Another paper by Garcia et al. demonstrated the encapsulation of DNase was in 
nanomolded particles.79 However, retention of biomolecule activity was not well documented. 
The authors only characterized activity by measuring size and conversion of methylene green in 
tris buffer solution. These tests may not have been sufficient enough to determine activity since it 
is known that the activity of DNase is negligible in solutions without calcium which was missing 
in their assays.80 Meaning that when the authors saw no difference in between encapsulated and 
free DNase, it might have been due to lack of activity to begin with. The biocompatibility of this 
technique still requires further investigation as most photopolymerization conditions are harsh to 
biomolecules unless the light intensity, irradiation time, temperature, and organic solvent levels 
are tightly controlled.81  
 
 
16 
 
 
Figure (1-5). Particle Replication In Nonwetting Templates (PRINT). Nanomolding technique 
designed by Rolland et al.78 
 
Microfluidics. Microfluidics was first developed as a technique to quantify small 
particles such as DNA and RNA.82 The devices are made via soft lithography of polymers such 
as poly(dimethylsulfoxane) and polyurethane. However, the usefulness of the micro scale fluidic 
channel devices has expanded their use into many areas of research. Nanogel synthesis with 
microfluidic channels has been demonstrated and is now frequently used in literature.83,84,85 
Control over nanogel size and dispersity can be accomplished by manipulation of parameters 
such as flow rate and solution pH. For example H. Zhang et al. demonstrated the synthesis of 
monodisperse alginate nanogels of diameter 70 nm. They achieved size control by adjusting the 
flow rate of both the aqueous and non-aqueous phase (Figure 1-6).86 This is one of the first 
systems used for the physical crosslinking of nanogels with the flexibility in synthesis to easily 
make nanogels of different sizes. They showed that multiple particle sizes can be made 
monodispersely without using different reactants or templates. Unfortunately, microfluidic 
devices are expensive to make and their output is very slow since their microsized channels can 
only pass one particle at a time.87 Although it is a good laboratory method to produce nanogels 
for biotherapeutic drug encapsulation, manufacturing carriers with this technique on any scale 
for medical applications might encounter problems in production costs and output. 
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Figure (1-6). Microfluidic synthesis of charge condensated nanogels. Channel A contains the 
calcium ion crosslinker in oil and channel B contains alginate polymer in water.86 
 
 
Self-assembly. The name of the self-assembly method explains itself. This technique 
uses components that have strong attractions to each other to self-assemble themselves into gel 
particles in aqueous solution. The two most common types of materials used in these systems are 
polymers and proteins. Some examples of nanogel components used for self-assembly include: 
wheat glutenin, thiolated heparin, biological copolymers, cholesteryl pullulan, and whey 
protein.88,89,57,90,91 Sizes of the resulting particles ranged from 40 – 200 nm and particle 
distributions were typically difficult to control or not reported. Synthesis of self-assembled 
particles is useful because it is very simple, fast, and does not require a purification step. 
However, the drawback to self-assembled particles is that there is a lack of flexibility in regards 
to size differentiation. Making particles of different sizes with self-assembly methods typically 
requires the use of new starting materials. In order to make a polymer carrier with a different 
size, a new polymer of a different molecular weight must be first synthesized. For protein 
particles, this presents even more of a challenge since they cannot be modified as easily. In these 
scenarios it is usually easier to just find another protein with a different identity instead of 
attempting modification. This issue results from the lack of control over the particle growth 
method. Since the driving force for the particle formation is not regulated by the experimentalist 
but is dictated by the strength of the attraction between the used materials, resulting particle size 
cannot be changed during growth and must be altered beforehand.57 
 
 
A 
B 
A 
A: mixture of soybean oil and (CH3COO)2Ca 
B: aqueous alginate solution 
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Table (1-1). A summary of current nanogel synthesis methods including benefits and drawbacks 
of each technique. 
 
 
It can be seen from this list of methods, that there is still a need for synthesis techniques 
that can form nanogel particles of different sizes with a low polydispersity using the same 
starting materials. The described methods suffer from inhomogeneity, difficult synthesis, time 
consuming purification, and/or inability to adjust particle size. Ideally, it should not be required 
that a new template or a new polymer be made in order to change the size of the resulting 
particles. Such constraints slow down synthesis by increasing complexity and raising production 
costs. Additionally, methods should not necessitate any slow purification steps or expensive 
materials in order to optimize the process for industrial application of encapsulated 
biotherapeutics.  
Therefore this thesis will outline a new procedure for an optimized nanogel synthesis that 
meets these requirements. Here we use enzymes to catalyze the crosslinking of biologically 
derived polymers to form nanogel particles of tunable sizes. Chapter 2 will cover synthesis and 
analytical techniques used to make and characterize the nanogel particles. Descriptions of 
instrument basics and data analysis as it pertains to nanogel particles is also outlined. Chapter 3 
will relate the results from the synthesis and particle characterization section. Correlations 
between data and trends observed will be presented in detail. Chapter 4 will discuss the 
conclusions we drew from the results of our study, the mechanism of nanogel synthesis, and 
future directions for the study of enzyme catalyzed nanogel particles. Lastly, chapter 5 will 
summarize the overall ideas presented in this thesis and the broader impact of the findings for 
drug delivery applications. 
Method Advantages Disadvantages Reference 
Microemulsion Simple synthesis Surfactant and purification 
required, high polydispersity 
Nesamony 
Nanomolding Homogenous and 
controlled size 
Toxic solvents and 
purification required  
Rolland, Garcia 
Micro/Nanofluidics Homogenous and 
controlled size 
Slow particle production and 
expensive synthesis 
Kasianowicz,  
Hong Zhang 
Self-assembly Simple synthesis 
No purification 
Particle sizes are fixed and 
unchangeable. Polydispersity 
usually high 
Reddy, Bae, 
Urakami, Muraoka, 
Gulseren 
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CHAPTER 2: SYNTHESIS AND CHARACTERIZATION TECHNIQUES.  
 
2-1) Synthesis of Nanogel Particles. 
 
We hypothesized that nanogel physical gelation could be induced with a synthesis 
scheme involving the use of 1). A biocompatible polymer that crosslinks in the presence of a 
specific cation and 2). An enzyme that catalyzes the formation of the specific crosslinking cation. 
This will allow crosslinking of the nanogels to be controlled by the enzyme’s activity as it 
dictates production of the crosslinker cation.   
For the synthesis of nanogel particles, we selected the polymer alginate as our matrix 
material. Alginate is a biodegradable polymer derived from seaweed that exhibits the ability to 
ionically crosslink in the presence of certain cations such as calcium and iron (III).92 These 
cations have the ability to bind to carboxylate groups and thus create ionic forces between the 
polymer and ions in a coordinated shape referred to as an “egg box” structure (Figure 2-1).92 
 
 
 
Figure (2-1). Ionically crosslinked “egg box” structure of alginate with specific cations.92 
 
 
 The second component used for nanogel synthesis was the laccase enzyme from the 
fungus Trametes versicolor. Laccase was chosen as it has been suggested to have the ability to 
convert iron (II) cations to iron (III) cations93,94  which can be used to crosslink the polymer.92  
However, the mechanism of this iron oxidation reaction is not entirely known.  Currently, it is 
not known which forms of iron reactant and product reside in the dissolved solution, iron oxide 
(Fe2O3), iron hydroxide (FeOH3), iron oxide-hydroxide (FeO(OH), or etc. We also hypothesized 
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in this work that laccase creates the iron III species in a redox reaction. We suggest that it takes 
an electron from iron (III) and transfers it to oxygen after which the reduced oxygen combines 
with hydrogen in solution to form water molecules (Figure 2-2). Similarly to other enzyme 
reactions, the iron conversion reaction in laccase is most likely a multi-step process that 
generates various intermediate complexes which affect the kinetics of the redox reaction and rate 
of product formation.95 Another important quality of laccase is that it creates no deleterious 
byproducts, only water. This allows for the synthesis of biocompatible nanogels with enzyme 
catalysis due to the absence of harsh biomolecule degrading components. Furthermore, 
encapsulation of biological therapeutics will be possible as the synthesis can be conducted in 
aqueous media, at physiological temperature, and at physiological pH. Since enzyme reactions 
are easily influenced by parameters such as reactant availability, temperature, and pH, we 
hypothesize that the use of an enzyme catalyst in nanogel formation will allow us to establish 
simple control over nanogel crosslinking and thus particle growth kinetics.   
 
 
 
Figure (2-2). Reaction of the laccase enzyme catalyst. Where X and Y are an undetermined 
anion. 
 
 
Lastly, we hypothesized that this nanogel synthesis method will allow us to control the 
size, polydispersity, and density of the particles via simple enzymatic control. All materials and 
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solvents used for this synthesis are commercially available and biocompatible.  It is also easy and 
quick since it can be conducted in one step. Therefore, we expect that utilizing an enzyme 
catalyst for the synthesis of nanogels will allow our particles to meet the aforementioned goals of 
a desirable nanosized drug delivery device. 
 
Chemicals and Reagents. The sodium alginate polymer and laccase from Trametes 
versicolor (E.C. 1.10.3.2) used for nanogel synthesis were purchased from Sigma-Aldrich. Iron 
(II) sulfate, sodium sulfate, 1,10-phenanthroline, sodium acetate, acetic acid, and phosphate 
buffer saline (PBS) were purchased from Fisher Scientific. All of the chemicals were used as 
received and not further purified. All solutions were made with ultrapure water (18.2 MΩ·cm; 
Barnstead Epure) and experiments performed at ambient temperature, 25°C ± 2 °C. pH of the 
solutions was measured with an Accumet AB15 Plus pH meter from Fisher Scientific.  
 
Proof of Gelation. To demonstrate gelation and understand the kinetics of bulk gelation, 
four solutions with different amounts of FeSO4, which was converted by enzymatic activity to 
iron (III) crosslinker, were monitored. All solutions were made with 0.67 wt% alginate and 0.44 
U/ml laccase enzyme in 50 mM sodium sulfate. Additionally, the first solution contained 1.67 
mM FeSO4, the second 15 mM FeSO4, and the third 32 mM FeSO4. The fourth sample was a 
control and contained 0.67 wt% alginate, 0 U/ml laccase enzyme, 15 mM FeSO4, 50 mM sodium 
sulfate. All solutions but the control exhibited visible gelation at different rates within 24 hours. 
 
Preparation of Films. Enzymatically crosslinked alginate bulk gels were dried to form 
films. To understand how film properties were affected by iron concentration, samples with 
varying levels of crosslinker were synthesized. The samples studied contained 0.67 wt% 
Alginate, 0.44 U/ml laccase, and FeSO4 at concentrations 0 mM, 1.67 mM, and 15 mM. 
Solutions were allowed to react for 24 hours at room temperature and then dried under vacuum 
in their reaction containers.   
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2-2). Characterization with UV-Visible Spectroscopy.  
 
The first technique used to measure the properties of the nanogel particles synthesized in 
this work was UV-Visible Spectroscopy (UV-Vis). UV-Vis is typically used to determine the 
concentrations of  uv sensitive components in a solution. It accomplishes this by exposing a 
solution to light and measuring the unabsorbed amount that passes through the solution. The 
unabsorbed quantity is subtracted from the intensity of the source to yeild the amount of light 
absorbed by the solution. Frequently, the intensity of absorbance is scanned over different 
wavelengths to find where peaks occur due to absorbance of certain solution components. Using 
Beer’s law, the concentration of the selected component can be calculated: 
𝐴 = 𝜀𝑏𝑐      (1) 
where A is absorbance, 𝜀 the extinciton coefficient of the absorbing moiety, 𝑏 the length of  
solution through which the light passes, and 𝑐 the concentration of the absorbing component.96 
The extinction coefficient is a value that is usually found in literature, since it can be simply 
calculated through the use of a concentration calibration curve. 
 
Absorption of light. Absorption occurs in solution when an energy source excites a 
molecule to a higher energy state (Figure 2-3). In this work, light from a tungsten and deuterium 
lamp are used in a Thermo Scientific Evolution 600 instrument to  excite the sample (Figure 2-
4). For the measurements presented in this thesis, two modes of the instrument were used: one 
where wavelength was held constant over time to measure kinetics, and one where wavelengths 
are scanned during a fixed amount of time to yeild the absorbtion spectra. 
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Figure (2-3). Absorption of energy resulting in excitation of a molecule with light. 
 
 
Figure (2-4). Schematic of UV-Vis instrument. A reference may be measured in the sample 
location and then removed and sample measured. The ratio between the two is analyzed by the 
software to measure the optical absorption.  
 
  
2-3). Characterization with Dynamic Light Scattering.  
 
In order to characterize the physically crosslinked nanogels synthesized in this work, one 
of the techniques used was Dynamic Light Scattering (DLS). DLS is a technique that measures 
the fluctuations of the refractive index of materials to understand motions in the sample such as 
the rate of diffusion, conformational flipping, and rotation. By identifying the time scale at which 
these movements occur, other information about the sample can be determined such as size, 
shape, density, polydispersity and etc.97 The nanogel particles synthesized in this study will be 
examined with DLS to determine their size, shape, and dispersity. DLS works by exposing 
optically polarizable molecules or particles to a monochromatic light source. The change in their 
polarizability elicited from their interaction with the wave interferes with the amplitude of the 
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incident electric field. Due to the direct mathematical relation between electric field and intensity 
(eq. 6), the intensity measured by the instrument is also altered from the particle wave 
interaction. So the intensity measured is the light from the source scattered by the interaction 
with the sample. Another way of understanding scattering is to view the phenomenon as the 
fluctuation of the local dielectric constant of the medium. Particles are constantly moving in the 
solution volume which alters the dielectric constant of the illuminated subregion due to the 
particle’s motions. 
Scattering data can be used to study translational motion which is measured as particles 
move in and out of the laser beam path to change its intensity. The scattered light in the 
experiments used in this thesis was collected at a 90˚ angle with respect to the incident light from 
a 671 nm solid state laser. It was then collected with a lens and objective and focused into a 
single mode optical fiber, then split between two avalanche photodiode detectors (Figure 2-5). 
The use of two detectors allowed the signal to be cross correlated and thus increased the dynamic 
range and reduced the noise of the instrument. 
 
 
 
Figure (2-5). Schematic of the DLS set up used. Kf is the wavevector of scattered light, Ki the 
wavevector of incident light, q the scattering wavevector, n the refractive index of the solution, θ 
the scattering angle, and λi the wavelength of the incident light.  
25 
 
The scattered electric field, Es, at time t and distance R from the solution can be described 
using the equation: 
𝐸(𝑅, 𝑡) = ((−𝑘𝑓2𝐸0 )/(4𝜋𝑅𝜀0))* 𝑒𝑖(𝑘𝑓𝑅 − 𝜔𝑖𝑡)𝛿𝜀𝑖𝑓(q, 𝑡)               (2) 
where E0 is the field amplitude, ε0 the average dielectric constant, and ωi the angular frequency. 
The last component, 𝜀𝑖(q, 𝑡), in the equation represents the dielectric constant fluctuation tensor 
along the initial and final polarization directions. 
Analysis of DLS data begins after the detector detects the incoming photons as a pulse. 
The correlator then calculates the intensity of the scattered light by counting the number of 
photons as a function of time and performs autocorrelation on the intensity function. Simplified, 
the autocorrelation function can be understood by the equation:   
𝑔2(𝑡) − 1 =
∑ (𝐼𝑡0−𝐼
̅𝑁−𝑡𝑡0 = 1 )(𝐼𝑡0+𝑡−𝐼)̅
(∑ (𝐼𝑡0−𝐼)̅
𝑁
𝑡0 = 1
)
2  -1            (4) 
or 
 𝑔2(𝑡) − 1 =
〈𝐼(𝑞,𝑡0)𝐼(𝑞,𝑡0+𝑡)〉
〈𝐼(𝑞,𝑡0)〉2
 -1           (5) 
where q is the scattering wavevector (in this case fixed at 90˚), t0 is time, t the length of a time 
segment (lag time),98 N the number of observations, I the intensity, and 𝐼 ̅the average intensity.99 
The use of the g2(t) indicates that the function is second order since intensity is equal to 
the electric field squared (equation 6) and the lowercase g relates that the function is 
normalized.97  
𝐼0 ≡ |𝐸0|
2      (6) 
In light scattering, if there is an exact repetition of a sequence of scattering intensity data 
from particle interference, the autocorrelation value assigned is 1. If there is no repeated pattern 
in the intensity fluctuations, such as white noise, the value is assigned as 0. These correlation 
values between 0 and 1 are plotted versus the time length of each repeat sequence (t) called lag 
time, to form an intensity correlation function (Figure 2-6). The lag time for translational motion 
can also be understood as the time that it takes for a particle to diffuse through a certain 
scattering volume. This scattering or illuminated volume occurs at the intersection between the 
incident and scattered beam.97 
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Figure (2-6). Example of how the correlation of intensity data is plotted versus lag time to obtain 
correlation functions. As the size of t increases, the correlation of the intensity fluctuations decay 
exponentially.98 
 
 
Measuring Translational Motion with DLS. To measure translational motion, the 
sample is illuminated with polarized light. When particles begin to move out of the path of the 
beam, signal correlation intensity drops. This indicates that a specific lag time is related to the 
diffusion of the particles out of the scattering volume. This specific time length is referred to as 
the characteristic decay time, or 𝜏𝑐. This parameter can be determined by fitting the intensity 
correlation curve with the function determined from taking the Fourier transform of the 
probability distribution function of finding a particle at a given scattering vector (q) and lag time 
(t): 
𝐹𝑠(𝑞, 𝑡) = 𝐼(𝑞, 𝑡) = 𝑒
(−
𝑡
𝜏𝑐 
)
     (7) 
Additionally, the decay rate, Г,  for translational diffusion is equivalent to: 
Г =
1
𝜏𝑐
= 𝑞2𝐷𝑡      (8) 
so that,  
𝐼(𝑞, 𝑡) = 𝑒
(−
𝑡
𝜏𝑐
)
= 𝑒(−𝑡𝑞
2𝐷𝑡)     (9) 
and combining with the Stokes-Einstein equation for translational diffusion, 
𝐷𝑡 = 𝑘𝐵𝑇/6𝜋𝜂𝑅ℎ     (10) 
I(
t 0
) 
<
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0
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can yield the hydrodynamic radius, 𝑅ℎ, of the solvated particle. This parameter may be 
determined after fitting the intensity data with an exponential decay function like the one shown 
in equation 9.97 In the Stokes-Einstein equation, kB is the Boltzmann constant, T the temperature, 
and 𝜂 the viscosity of the solution. 
  
Fitting of Correlation Functions. In this thesis, three types of functions were used to fit 
the correlated scattering intensity data.  
The single exponential decay, 
𝑔(2)(𝑡) − 1 = (𝐴 ∗ exp (−
𝑡
𝜏𝑐
))
2
+ 𝑦0 .        (11)  
The stretched exponential decay, 
𝑔(2)(𝑡) − 1 = (𝐴 ∗ exp (−
𝑡
𝜏𝑐
)
𝛽
)
2
+ 𝑦0 ,          (12) 
And a function with two decays, the first being a single exponential and the second a stretched 
exponential. 
𝑔(2)(𝑡) − 1 = (𝐴1 ∗ exp (−
𝑡
𝜏𝑐1
) + 𝐴2 ∗ exp (−
𝑡
𝜏𝑐2
)
𝛽
)
2
+ 𝑦0.            (13) 
where A is the amplitude of the intensity, t the lag time, 𝜏𝑐 the characteristic decay time, and β 
the stretching parameter. One reason the β (or stretching) term may be required in the fitting 
function is that there is a broad distribution of particle sizes in the sample which prevents them 
from being distinguished. An example of this can be seen in Figure 2-7 where all of the shown 
decays are components of the normalized stretched decay (pink dashed line). Here, the overall 
decay curve (pink dashed line) that represents many types of particle sizes is more stretched than 
its component functions that only represent one particle. Therefore within the one decay curve, 
there are present a large diversity of correlation times and thus particle sizes which represents 
polydispersity. The particle polydispersity is represented by the term β in the fitting equation 12 
and 13. When β is equal to 1, meaning the function can be fit with a single exponential decay 
model, then it can be said that all particles are of the same size and monodisperse. This means 
that all of the particles have the same diffusion coefficient and the same hydrodynamic radius. 
As β decreases, stretching increases and thus polydispersity of the sample grows. This indicates 
that the diffusion coefficients and sizes of the particles are varied.97 
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Figure (2-7). Example of how a stretched correlation function is formed. The pink dashed line is 
an example of the real function that would be seen upon combining all of the other pictured 
decays. With polydisperse samples the decay function becomes stretched. (Figure modified from 
Mallamace et al.100 ) 
 
 
2-4). Characterization with Atomic Force Microscopy. 
 
The third technique used to characterize properties of the nanogel particles was Atomic 
Force Microscopy (AFM). AFM is a technique that is frequently used to complement DLS. It is 
used to measure the topology of deposited particles and other surfaces. When studying the 
characteristics of  particles it can determine their size, dispersity and height among others.  
Although the sample size measured by the technique is small, the main advantage of using AFM 
is that it obtains an image of the sample for visual inspection. Additionally, the image resolution 
can be on the atomic scale making the technique very accurate.101 
AFM works by scanning the surface of a sample with a nanosized instrumental tip 
attached to a flexible cantilever to determine the sample’s topography. Attractive and repulsive 
forces between the tip and sample cause deflection of the tip duing scanning. This deflection is 
               Real signal from sample 
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measured by a laser that is reflected off of the tip onto a detector. Therefore, changes in tip 
deflection may be detected and interpreted as topography of the sample.101 In AFM, the type of 
material and size of the tip used determines the resolution of the image.102 Here, a silicon tip of  
<10 nm in diameter was used for imaging.  
There are several different modes that can be used to measure a sample with AFM. These 
are demonstrated in Figure 2-8 and are known as: contact, non-contact, and tapping. Contact 
mode maps topography by dragging the tip along the sample surface. Forces between the sample 
and tip measured in this mode are repulsive. The second mode, non-contact, modulates the tip at 
a resonance frequency and monitors any changes due to attractive force interactions with the 
sample. As the frequency and amplitude of the tip changes due to force interactions, the 
computer adjusts the distance between the sample and tip so that the the frequency and amplitude 
remains constant during scanning. This mode keeps the tip very close to the sample so that the 
force interactions between them are still measured even though no contact is made.103 The third 
mode, Tapping, or intermittent contact mode, is achieved by applying force such that the tip goes 
in and out of the non-contact and contact mode regions.Therefore in tapping mode both attractive 
and repulsive force interactions are present between the sample and the tip.  
 
 
 
Figure (2-8). Example of the common scanning modes of AFM. (A) Represents contact mode, 
(B) Non-contact mode, and (C) Tapping mode where the tip oscilates in the Z direction as it 
scans. 
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2-5) Characterization with Small Angle Neutron Scattering. 
 
Small Angle Neutron Scattering (SANS) is a technique that works by measuring the 
scattering signal that originates from interactions between neutron waves and atomic nuclei of 
sample matter. This causes the resulting scattering intensity to be dependent on the strength of 
the nucleus-neutron interactions, which is known as the scattering length density (ρ). Due to the 
relationship between scattering strength and the identity of the atoms that neutrons pass through, 
SANS can be used to distinguish between isotopes of the same element. Normally hydrogen and 
deuterium are used for experimental contrast since the scattering length density of hydrogen is 
much larger than its isotope and the element is plentiful in organic samples. Additionally, 
hydrogen can be exchanged with deuterium in most samples and the change usually does not 
significantly affect the system dynamics.104 
In typical experiments, H2O and D2O mixtures are used to view scattering in samples due 
to their strong differences in neutron-nucleus interactions, identified by the scattering length 
density (ρ). By changing the percentage of hydrogen and deuterium in a solvent, the 
experimentalist can effectively tune the scattering length density to be as close to pure H2O or 
pure D2O as desired. This optimizes contrast since it is determined by the difference between the 
solvent and particle scattering length density: 
𝑐𝑜𝑛𝑡𝑟𝑎𝑠𝑡~ 𝜌𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒 − 𝜌𝑠𝑜𝑙𝑣𝑒𝑛𝑡        (18) 
Finding the solvent mixture of H2O and D2O that yields the largest difference between 
ρparticle and ρsolvent is used to maximize the intensity signal scattered from the particles in solution. 
Furthermore, contrast is very important in SANS because the flux of the neutron source is very 
low due to the manner in which neutrons are generated for scattering applications. Without 
proper minimization of background noise, the typically weak signal from the sample may be 
easily overwhelmed.  
One reason why SANS was used in this work is because it allows us to more accurately 
view our nanogel particles in the semi-dilute regime since it is known that at this concentration 
they cannot be accurately viewed with DLS. In SANS, the concentration of particles is not 
problematic because intensity of the scattered signal only depends on the identity of the atomic 
nucleus (H or D) of the material. Therefore signal from small particles in neutron scattering is 
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not overwhelmed by signal from large particles so that we can obtain an average size of all of the 
particles in solution. Another characteristic unique to SANS is that the size range that 
instruments are able to access typically lies anywhere between 0.5 nm to several hundreds of 
nanometers, due to the small wavelength of incident neutrons.105 To see structures of different 
sizes in this range, the scattering wavevector, q, must be adjusted through manipulation of the 
scattering angle. The wavevector has an inverse relationship with the probe distance, d, of the 
sample being examined106: 
𝑞 =
2𝜋
𝑑
                         (19) 
Therefore, within the q range of the instrument used to study our nanogel particles, 0.00009-0.08 
nm-1, the size of objects that can be viewed lies between approximately 0.8-700 nm. Adjusting 
the wavevector q may be accomplished by changing either the scattering angle θ or the neutron 
wavelength λ in order to probe different length scales within the sample since: 
𝑞 =
4𝜋
𝜆
sin (𝜃)       (20) 
In figure 2-9, a demonstration of how q is manipulated through variance of sample distance (ds) 
from the detector is shown. 
 
Figure (2-9). A schematic presentation of a typical neutron scattering experiment. As ds 
increases, θ decreases, and thus q decreases as well. Here kf is the scattered wavevector, ki the 
incident wavevector. 
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Analysis. One way to plot neutron scattering data for analysis is to graph the intensity 
I(q) versus the scattering wavevector q. Since q has an inverse relationship with the probing 
distance (d), this can give information on the sizes of structures in the solution such as the radius 
of the particles or the size of the nanogel pores.107 When q is large, the probing distance is small, 
therefore the interior structure of the particles (pore size) is being studied. When q is small, the 
probing distance is large so that the radius of the particles can be viewed.  
A change in the slope of the scattering intensity is directly related to the size and shape of 
the structures in the solution. A change in slope indicates when q has increased enough to switch 
from probing the whole particle to the interior pore space of the particle. This is due to the 
relation: 
𝐼(𝑞) = 𝑃(𝑞) ∗ 𝑆(𝑞)      (21) 
where P(q) is the form factor and S(q) is the structure factor. The Structure factor S(q) describes 
the scattering interference between different particles and P(q) the change in scattering from 
different parts of a single particle. When there is no contribution to interference by interparticle 
interactions, (i.e. in the dilute regime) S(q) effectively equals 1.108 Contained within the  
form factor function is the scattering length density distribution function ρ(r), where r represents 
position: 
𝑃(𝑞)~𝜌(𝑟)                (22) 
The exact relation between P(q) and ρ(r) will be explained later in this section. However, 
it is important to understand that ρ(r) is dependent on the changes in scattering length density (ρ) 
that occur as neutrons pass through positions (r) of a sample. The scattering length density is a 
parameter that represents the inherent scattering strength of a material. So as neutrons scatter 
from the particles they have a scattering length density of ρparticle and when scattered from the 
solvent ρsolvent. Therefore ρ(r) represents what value ρ becomes when scattering occurs at 
different positions (r) in the solution:  
𝜌(𝑟) = 𝜌𝑖𝛿(𝑟 − 𝑟𝑖)        (23) 
where ρ(r) represents the scattering length density distribution function, ρi the scattering length 
of the relevant material, and r position.108 In Figure 2-10, the change that occurs in scattering 
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length throughout a sample is demonstrated. Furthermore, it represents an example of how 
contrast tuning with H2O and D2O is utilized to enhance ρ from selected components (solute or 
solvent) in solution. In (A) the scattering length of the solvent is set to be low and in (B) the 
scattering length of the solute is said to low. This change in p(r) directly alters the form factor 
P(q) which in turn changes the intensity I(q) of scattering from either the solute or solvent. This 
allows the experimentalist to maximize signal from either the particles (solute) or pores (solvent) 
through contrast adjustment while using the same analysis method to analyze the results.104 
 
 
Figure (2-10). How scattering length fluctuates as neutrons interact with different parts of the 
solution. Scenario (A) is when the particles are being analyzed at low q and (B) when pores are 
being analyzed at high q. The scattering length density of either solute or solvent may be set to 
the lower value using contrast adjustment with H2O and D2O. 
 
 
Low q Analysis. To find the radius of the nanogel particles, q must be sufficiently small. 
This area, called the Guinier region, occurs when: 
 𝑞 ≪
1
𝑅𝑔
       (24) 
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 By plotting ln (I(q)) vs q2, the slope of the data in the Guinier region can be used to 
determine the radius of gyration without knowing the shape of the structures using the 
equation108: 
𝑙𝑛(𝐼(𝑞)) = 𝑙𝑛(𝐼𝑏𝑘𝑔) −
𝑞2𝑅𝑔
2
3
     (25) 
where Ibkg is the initial intensity from the background. An example of the Guinier region and 
how it can be used to find particle size is shown in Figure 2-11.     
 
High q Analysis. To determine the structure of the gel pores, analysis was performed in 
the high q or Porod regime which is defined to occur when: 
 𝑞 ≫
1
𝑅𝑔
       (26) 
In this regime, unlike in the Guiner regime, the form factor P(q) is dependent on shape 
and internal stucture of the particles. Therefore an equation that relates the scattering intensity 
per unit volume, I(q), to the volume fraction, , 𝜑, and the form factor P(q) is used: 
𝐼(𝑞) = 𝜑𝑃(𝑞) + 𝐼𝑏𝑘𝑔     (27) 
where Ibkg represents the incoherent scattered background. To determine information about the 
particles in this size scale, the shape and therefore the density distribution function, of the 
structure must be known.104 Shown in Figure 2-11 is an example of the Porod region from 
neutron scattering data and how it depends on shape and internal structure. However, for our 
particles, the density distribution function was not known, so a different fitting approach had to 
be utilized. To describe the hierarchy that exists in polymer gels, a generalized Porod’s law was 
used to relate structural information.110 
𝑃(𝑞) = (
[𝑒𝑟𝑓(
𝑞𝑅𝑔
√6
)]
3
𝑞
)
𝑃
                                        (28) 
where erf is the error function, q the scattering wavevector, Rg the radius of gyration, and P the 
Porod exponent. This approach applies a generalized scattering function to the data to limit the 
parameters used in fitting so that it may relate structural information over a wide range of q 
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values. Other more specific models were attempted to fit the data, but the parameters obtained 
from the fits were not physically relevant or did not contribute meaningful information to the 
analysis without further experimentation. 
 
Instrument Configuration. Small Angle Neutron Scattering was carried out at the CG-3 
Bio-SANS instrument located in the High Flux Isotope Reactor (HFIR) at the Oak Ridge 
National Laboratory (ORNL) with a Q range of 0.00009-0.08 nm-1.105 Two instrument 
configurations were used to cover a wide range of scattering vectors, 0.0003 < q < 0.04  nm–1, 
i.e., sample-to-detector distances of 2.529 m and 15.329 m with a fixed λ of 0.6 nm.  The 
instrument resolution was defined by the placement of circular apertures (diameters), 40 mm as 
source and 14 mm as sample, at a separation distance of 17.430 m.  The area detector, 1 m x 1 m 
GE-Reuter Stokes Tube detector used for collecting scattering and transmission data, was offset 
by 400 mm from the beam center for the experiment. Data reduction and analysis were 
performed using the IgorPro software package.105,112 Raw 2D images were processed by 
normalizing to incident beam monitor counts and correcting for detector dark current, pixel 
sensitivity and subtracting cell background scattering.   
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Figure (2-11). An example of how the form factor P(q) changes with q for cylindrical particles. 
The red circle represents how the probed distance (d) changes with q variation.107 
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2-6). Characterization with Viscometry and Rheology.  
 
To find the viscosity of the solution studied in DLS, mixtures containing different 
concentrations of alginate were studied with viscometry and rheology. This provides a good 
estimate of overall solution viscosity because alginate is by far the most viscous component of 
the nanogel synthesis reactants, with the others contributing negligibly. Due to differences in 
fluidity of dilute and concentrated alginate solutions, two techniques were used to determine 
their viscosity: Ubbelohde Viscometry and Rheology.  
 
Ubbelohde Viscometry. Viscometers measure solution viscosity by measuring the 
amount of time it takes for a solution to travel between two calibrated distances.113 Our dilute 
alginate solutions were studied with this technique. Using the Hagen-Poiseuille Law, the 
volumetric flow rate can be related to viscosity, η: 
𝑉
𝑡
=
𝜋𝑅4𝛥𝑃
8𝐿𝜂
       (30) 
where V is volume, t is time, R the radius of the tube and L the length of the tube. The pressure 
change, ΔP, is equivalent to the product of the density of the solution (ρ), gravitational 
acceleration (g), and the height of the mean hydrostatic pressure (hm): 
∆𝑃 = ρ𝑔ℎ𝑚       (31) 
Here we assumed that ρ for the solution was the same as water since the percent of polymer we 
chose to study remained below the dilute limit. During experiments, volume was held constant so 
that the only unknowns to be determined were viscosity, η, and time, t. Therefore, the viscosity 
of the solution can be found by taking the ratio of time (t0) to viscosity (η0) of the solution and 
comparing it to that of water (tw and ηw): 
𝜂0
𝑡0
=
𝜂𝑤
𝑡𝑤
                    (32) 
 Rheology. Rheology is the second technique we used to measure solution viscosity. It 
calculates viscosity through measurement of the strain and stress of a material.114 Due to the high 
viscosity and thus low flow rate of concentrated (above the dilute limit) alginate, measurements 
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of 1 wt% polymer were determined with a rheometer instead of Viscometry. Rheometers 
measure viscosity by applying stress (creep test) or strain (startup shear) forces to a sample 
wedged between two mechanical plates in a chamber at a controlled temperature. The first 
quantity measured by the instrument, shear rate (?̇?  or strain rate), is defined by: 
?̇? = 𝑈/ℎ       (33) 
where U is the velocity of the top plate in the x direction and h the height difference between the 
plates. The second quantity, shear stress (т or stress), is defined by: 
т = 𝐹/𝐴       (34) 
where F is the shear force on the top plate, and A the area of the sample in contact with the plate. 
Taking the ratio of these two yields the viscosity of a solution115:  
𝜂 = т/?̇?       (35) 
The way viscosity is measured for polymers is through the zero shear viscosity value 
(𝜼𝟎) determined via a rheological creep measurement (Figure 2-12). Creep experiments apply a 
fixed stress to the material and measure the resulting strain over time. When the strain rate reaches 
equilibrium, the zero shear viscosity can be found using116:   
𝜂0 = т0/?̇?0       (36) 
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Figure (2-12). Example of a creep experiment. Where the dashed line represents the 
applied stress (т) and the black line the resulting strain rate (?̇?) of the material. When the curve 
reaches equilibrium at the top, the zero shear viscosity can be determined.117  
 
 
Combining the viscosity values found from both viscometry and rheology, a curve of 
viscosity versus concentration can be plotted. When concentration of a polymer solution is 
extrapolated to zero from this calibration curve, intrinsic viscosity [η], can be found. This value 
is useful because it allows for the calculation of the polymer mass using the Mark-Houwink 
equation for an aqueous alginate solution118: 
 [𝜂] = 0.035𝑀0.66      (37) 
where the value 0.66 in this equation is specific to the polymer-solvent pair and temperature. The 
radius of gyration, Rg, for our alginate polymer was found using the Fox Flory equation
113:  
𝑅𝑔 = √[𝜂] ∗
𝑀𝑤
ϕ
3
      (38) 
where[𝜂] is the intrinsic viscosity, ϕ the Fox Flory constant, and Mw the polymer molecular 
weight. 
Viscometry and Rheology Experimentals. The viscosity of several alginate solutions 
with different weight percentages were determined. Viscometry was used to measure the dilute 
solutions, and rheology was used to measure the concentrated 1 wt% solution. For the dilute 
т 
т 
?̇? 
?̇? 
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solutions, a Cannon-Ubbelohde Dilution Viscometer, model B941, was used at 18˚C for 
characterization. To calculate viscosity of the alginate solutions, the flow time of the alginate 
solution was compared to that of pure water. Creep shear measurements were performed on an 
AR2000ex rheometer for the concentrated 1 wt% alginate solution under the stress of 10 Pa at 
18˚C. To ensure accuracy of the measurements, a cone plate with a diameter of 60 mm, cone 
angle of 2˚, and truncation length of 49 μm were selected for use.  
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CHAPTER 3: RESULTS 
 
 
3-1). Enzymatic Induced Gelation. 
 
3-1-1). Enzyme Kinetics 
 
Iron (III) Formation in Buffer. The kinetics of iron (II) oxidation in buffered solutions 
was studied using UV-Vis. The absorbance of enzyme containing soultions was monitored at 400 
nm for 20 min. The samples consisted of 50 mM sodium acetate buffer, 0.72 mM iron (II) 
sulfate, and different concentrations of laccase (0, 0.1, 0.5, and 1 U/ml). The iron (II) sulfate was 
added to the solution just before measurements of the iron (III) acetate complex began. A pH of 
6 was mantained throughout the experiment in order to optimize enzyme activity and prevent 
iron precipitation. Afterwards, an identical experiment was run except that all solutions were 
made in D2O so that the kinetics could be compared to the samples in H2O to complement the 
analysis of later collected neutron scattering data. 
 
Results. In buffered acetate solution made with water, our results show a plateau in iron 
conversion rates after 10 minutes with a solution of 1 U/ml laccase, after 20 minutes with 0.5 
U/ml laccase, and no plateau with 0.1 U/ml laccase within the 20 minute window. Such 
variances demonstrate that the speed of the reaction depends on the amount of laccase at the 
represented concentrations (Figure 3-1). 
The results from an identical experiment performed in D2O are also shown in Figure 3-1. 
It can be seen that enzyme activity in D2O is reduced, however, overall the system produces 
more iron (III) acetate. This means that the enzymatic reaction in D2O takes longer to saturate so 
that it reaches a much greater absorption maximum. It was also observed that oxidation of iron 
by ambient oxygen in solution (black lines Figure (3-1)) was reduced in the D2O environment. 
These results were used to help elucidate data collected later by neutron scattering experiments. 
 
Iron (II) Dissapearance. To further confirm iron conversion, a second experiment was 
run where the consumption of iron (II) instead of production of iron (III) was measured. 1,10-
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phenanthroline is known to bind to iron (II) to form a complex that absorbs at 508 nm. A stock 
solution consisting of 50 mM acetate buffer, 0.72 mM iron (II)sulfate, and 0.5 U/ml laccase was 
assembled. Approximately every 2 minutes a 100 μl aliquot of solution was drawn and mixed 
100 μl of (0.167 mM) 1,10-phenanthroline in 1.8 ml of water. A second sample with no laccase 
was run parallel to the first as a control. Resulting iron (II) concetrations were calculated using 
the Beer-Lambert law and the molar extinction coefficient of ε512 = 11.1 mM−1 cm−1.119 
 
Results. It was found that disappearance of iron (II) during a reaction with 0.5 U/ml 
laccase was significant in comparison to the control sample, (Figure 3-2 (A)) confirming 
enzymatic conversion. Therefore we can firmly claim that laccase catalyzes the conversion of 
iron (II) to iron (III) based on our UV-Vis studies. 
 
 
 
Figure (3-1) Absorbance of iron (III) acetate complex at 400 nm, pH 6.0. Solid lines represent 
samples in D2O and dashed lines in H2O. Samples additionally contain laccase concentrations of 
0 U/ml (black), 0.1 U/ml (green), 0.5 U/ml (red), and 1 U/ml (blue). The pink dotted line 
represents the max absorbance of 1 U/ml laccase in D2O at its plateau (occurs at a time not 
featured). 
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Oxygen Limitation. To observe the effect that oxygen (an enzyme reactant) has on the 
kinetics of the reaction, a similar experiment was run under argon (Figure 3-2 (B)). Two separate 
solutions containing 50 mM acetate buffer and 0.5 U/ml laccase and 0.72 mM iron in water were 
bubbled with argon gas for 20 minutes before combining and measuring kinetics. Midway during 
the reaction, the sample was mixed throughly to reincorporate oxygen into the solution and 
observe the change in kinetics.  
 
Results. It was found that argon saturation significantly slowed enzyme activity and that 
it could be recovered with re-oxygenation. This assay shows that the enzyme reaction can be 
easily controlled by substrate (oxygen) availability. Furthermore, it means that the production of 
iron (III) crosslinker in solution can be easily tuned via the enzyme reaction and thus affect the 
kinetics of nanogel particle growth.  
 
 
 
Figure (3-2). Graph (A) shows the concentration of iron (II) calculated from the 
absorbance of the iron (II) 1-10 phenanthroline complex at 508 nm. The black line is a control 
with 0.72 mM iron (II) sulfate in 50 mM acetate buffer and the red line sample additionally 0.5 
U/ml laccase. Graph (B) shows a sample containing  0.72 mM iron sulfate and 0.5 U/ml laccase 
in 50 mM acetate buffer, pH 6 under argon (dark red line) and ambient atmosphere (red line). 
The arrow indicates the point at which the mixture was stirred to oxygenate the solution. The 
black line is a control with the same components, but no laccase.  
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3-1-2). Polymer Molecular Weight 
 
Another property of the solutions studied was viscosity. The viscosity of several alginate 
solutions, 0.02 wt%, 0.035 wt%, 0.05 wt%, 0.07 wt% and 1 wt% were determined. 
Measurements were repeated five times each to reduce error. Molecular weight of the polymer 
was calculated from the viscosity measurements of the alginate solutions (Figure 3-3). The 
intrinsic viscosity [η], was found to be 1340 ml/g and the maximum polymer molecular weight 
333 ± 23 kg/mol from the Mark-Houwink equation for alginate solutions (eq. 37). The maximal 
radius of gyration for alginate in solution was found to be 32 nm using the Fox-Flory equation 
(eq. 38).  However this number will vary from the radius of gyration determined from SANS 
measurements as it measures the average value instead. Due to the large polydispersity of the 
alginate polymer, the maximal and average radius of gyration should be different.  
 
3-1-3). Gelation. 
 
Gelation of the bulk material was also explored. Since gelation/crosslinking can not occur 
without iron (III) present, the speed of the gel formation can be attributed to the speed of iron (II) 
oxidation with or without the laccase catalyst. Here we investigated gelation due to iron 
conversion in an aqueous solution under an air atmosphere. It was found that gelation rate of a 
solution could be slowed with decreasing amounts of  iron crosslinker. It was found that when 
combined with 0.67 wt% alginate and 0.03 mg/ml (0.44 U/ml) laccase, a sample with 32 mM 
iron showed bulk gelation after 6 hours, 15 mM after 18 hours, and 1.67 mM no gelation within 
24 hours. A control sample without laccase only exhibited signs of gelation after 3 weeks in 
solution indicating laccase accelerated the oxidation rate of iron (II) greatly.  
These samples were then dried under vacuum at room temperature until the water was 
completely removed and films were formed. A slight yellow tint colored the films due to iron 
(III) content. Additionally, the clarity of the films varied based on the amount of iron in the 
solution (Figure 3-5). As the iron content increased, the more transparent the films became. We 
speculate that this change in transparency is due to the amount of water in the dried films. Free 
iron (III) is known to be hydrophobic in solution. Therefore, as iron (III) content increased in 
solution, more water may have been driven out of the film.   
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Figure (3-3). Viscosity data plotted versus concentration, c, to estimate the intrinsic viscosity [η]. 
 
 
         
Figure (3-4). Demonstration of bulk gelation. Alginate and iron in the absence (A) and presence 
(B) of laccase enzyme. 
 
 
 
Figure (3-5). Films synthesized with 0.67 wt% alginate, 0.03 mg/ml (0.44 U/ml) enzyme and 
iron (II). The films are overlaid on top of the words in the bottom right corner. Iron 
concentrations are 0, 1.67, and 15 mM which correspond to samples labeled: 0, 100 μl and 900 
μl. 
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3-2). Enzymatic Production of Nanogel Particles. 
 
3-2-1). Dynamic Light Scattering.  
 
Experimentals. DLS was used to study the dynamics of the particle’s growth in solution. 
It allowed for the calculation of particles sizes, particle polydispersities, and particle growth 
rates. The solution studied with DLS was within the dilute limit for polymers, meaning that the 
polymer coils were well separated in solution and not entangled. Below the dilute limit it  is 
known that the formation of nanoparticles is favored in solutions.120 The limit at which solution 
viscosity may no longer be considered dilute was calculated using121: 
𝜌∗ =
𝑅𝑔𝑀3
𝑁𝐴4𝜋
             (14) 
where ρ* is the viscosity at which polymers become entangled, Rg the radius of gyration, M the 
molceular weight of the polymer, and NA Avogadro’s number. The amount of polymer used for 
these experiments was below ρ* indicating that measurements were performed on a dilute 
solution. 
To examine if particle growth kinetics could be controlled, two concentrations of 
crosslinker precursor (iron II) were studied in solutions. To synthesize nanogel particles, a 
solution was prepared of the following components: 0.07 wt% sodium alginate, 0.187 U/ml 
laccase enzyme, and 0.0714 M Na2SO4. These were run through 0.22 μm polyethersulfone filters 
2-3 times until the dust particles and large aggregates were removed from the solutions. A stock 
solution of FeSO4 was filtered separately and added to the sample for final concentrations of 0.36 
mM and 3.6 mM. Scattering measurements were initiated at the time of iron sulfate addition. 
Intensity data was collected in one minute increments by the instrument and the intensity 
correlation function was calculated with an ALV-7004/USBFAST digital correlator. Functions 
were fit with equations 11-13 and hydrodynamic radius calculated using equations 9 and 10. The 
viscosity of water (1.33 cp) was used in the Stokes equation to calculate particle hydrodynamic 
radius.  
 
Results. It was found that solutions containing 0.014 mg/ml (0.187 U/ml) laccase 
enzyme, 0.07 wt% alginate, and 0.36 and 3.6 mM iron exhibited changes in nanogel particle size 
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and polydispersity during the growth cycle. The correlation functions of the particles in solution 
over time can be viewed in Figure 3-6 (A and B). Throughout the growth process, three distinct 
regions were observed and were fitted with 3 different correlation functions (Figure 3-7). The 
first function was a stretched exponential decay and is shown in equation 11. The second 
function was a single exponential decay and is demonstrated in equation 12. The last function 
consisted of two exponentials, a stretched decay and a single decay and is shown in equation 13. 
Using the characteristic decay time found from the fittings, the diffusion coefficients of the 
particles in solution were calculated (eq. 9). Using the Stoke-Einstein equation (eq. 10), the 
hydrodynamic radius of the particles was calculated from the diffusion coefficients.  
When the hydrodynamic radius of the particles was plotted versus time, three distinct 
regions of growth appeared during nanogel formation (Figure 3-8). Region I is an area where 
slow or no growth occurred. Region II is an area where a fast increase in particle size manifests. 
Lastly, in Region III, particle growth tapers off and in the case of the 3.6 mM iron sample, also 
splits into two separate processes. 
Additionally, the polydispersity of the particles was measured via the beta exponent, or 
stretching parameter of the correlation functions. The stretching of a function indicates the 
presence of multiple sizes of particles. It is also plotted in Figure 3-8 to show how 
stretching/polydispersty changes depending on the growth region. Both samples were found to 
have a low beta, or high polydispersity, in region I. However, after region I, growth begins in 
earnest and beta quickly jumps up near 1 indicating the formation of nearly monodisperse 
populations of particles toward the end of region II. Region III exhibits a high beta, or low 
polydispersity. However, in the 3.6 mM iron sample, a second process (shown in red in Figure 3-
8) was formed that was very polydisperse in nature. In the case of the 0.36 mM sample, the 
second highly polydisperse process never develops so that beta remains high and polydispersity 
of particle sizes low.  
It is also interesting to note that as the iron concentration increased, the time in which it 
took the particles to reach a monodisperse size was reduced. By increasing the availability of 
iron (II) cations by ten times, the speed of the growth process increased by ten times. For the 
0.36 mM sample, region III was reached at 1600 minutes whereas for 3.6 mM it occurred at 
~300 minutes, demonstrating a dependence of the speed of particle growth on the availability of 
iron crosslinker. Overall, nearly monodisperse populations of alginate nanogel particles were 
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formed from samples with two different concentrations of iron. For 0.36 mM iron, particle 
polydispersity remained very low between 34 and 44 nm and in the case of 3.6 mM iron between 
47 and 100 nm.  
 
 
 
Figure (3-6). Change in the normalized intensity correlation functions of (A) 0.36 mM iron and 
(B) 3.6 mM iron over time.  
 
 
Figure (3-7). The three types of correlation functions observed throughout nanogel growth. 
These were fit with equations 11-13 (stretched exponential, single exponential, and single 
exponential + stretched exponential) and the hydrodynamic radius (RH) was calculated with the 
Stokes-Einstein relation (eq. 9). The reduced χ2 value represents the quality of the fit when used 
with the specified equation. 
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Figure (3-8). (A) Change in the hydrodynamic radius and stretching parameter, β, 
(polydispersity) of the particles over time when synthesized with (A) 0.36 mM iron and (B) with 
3.6 mM iron. The three regions are marked as I, II, and III. The red points in (B) represent a 
second process that develops only in region III of the 3.6 mM iron sample. The dotted green line 
is a base line representing the size of particles present in a control sample with no iron. 
 
 
3-2-2). Atomic Force Microscopy. 
 
Experimentals. Samples for AFM analysis were synthesized by combining 0.07 wt% 
alginate, 0.262 U laccase, and 0.36 and 3.6 mM Fe2SO4 in 0.0714 M NaSO4 solution. Stock 
solutions were left to react and aliquots withdrawn at different time intervals to image the growth 
process as it occurred. Samples were deposited and dried on a silica substrate for AFM analysis. 
AFM of nanogel particles was performed in tapping mode of the commercial instrument, Asylum 
Cypher. Collected images were analyzed with the WSxM image analysis program. Using cross-
section analysis, the width and height of the particles were determined.  
In AFM, two artifacts from the instrument usually appear during scanning: broadening of 
the particle size due to the tip shape and height lowering of particle size due to elastic 
deformation.  Profile broadening of particle radius occurs because the tip has finite width and 
thus the reported size of the particles from the instrument is composed of the real width of the 
particle convoluted with the width of the tip (Figure 3-9). Therefore the radius of the particle 
must be deconvoluted from radius of the tip using the equation: 
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𝑟𝑐 = 2√𝑅 ∗ 𝑟     (16) 
where rc represents the distance between the center of the tip and center of the particle, R the 
radius of the tip, and r the radius of the particle.122 We assumed that height of the particles was 
negligibly affected by deformation since the measurements were taken in tapping and not contact 
mode. It was assumed that deposition caused surface confinement of the hydrophilic particles 
and forced them to form spherical cap shapes.123 Therefore, the volume of the non-deposited 
particles was calculated using the assumption that the volume of the spherical cap was equal to 
the volume of a sphere: 
𝑉𝑠𝑝ℎ𝑒𝑟𝑒 =
4
3 
𝜋𝑟3 =
1
3 
𝜋ℎ2(3𝑟 − ℎ) = 𝑉𝑐𝑎𝑝     (17) 
 
 
 
  
Figure (3-9). Tip broadening due to A). a tip with no width (ideal = no tip broadening), and B). a 
tip with width (real).124 
 
 
Results. Using AFM, the nanogel growth process was captured in two different regions, 
II for 0.36 mM iron and III for 3.6 mM iron. The size distributions in Figure 3-10 (C) and (D) 
correlate with the DLS results in Figure 3-8 (A and B). From the image of the 3.6 mM iron 
particles (Figure 3-10 (B)), it can be seen that when imaged in region III, aggregation was indeed 
the reason why a second process in DLS appeared.  
A). B). 
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Figure (3-10).  AFM images and size distributions of nanogel particles diluted 50 times from 
their original solutions. The growth process of the 0.36 mM sample was imaged in regime II (A) 
and the 3.6 mM sample in regime III (B). The size distributions are shown in (C) and (D) for 
their respective images. 
 
 
 
 
Figure (3-11). (A) shows the nanogel particles after 60 min of reaction with 3.6 mM iron. B) is a 
control with only laccase (0.187 U/ml), and C) a control containing laccase (0.187 U/ml) and 
alginate (0.07 wt%) but no iron. 
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Additional confirmation of the association of the second process with aggregation was 
obtained through independent estimates of the average distance between nanogel particle centers 
in solution. Calculation of the average distance between particle centers was conducted under the 
assumption that each enzyme seeds the growth of an individual particle. So that enzyme 
concentration is the reagent that limits the number of particles seeded in the solution. The total 
solution volume was 1.4 ml and the enzyme concentration 0.187 U/ml (equal to 3 × 10−10 mol 
based on molecular weight of ca. 66 kDa for fungal laccases125 or N = 1.8 × 1013 particles in this 
volume). The conversion from milligrams to units of enzymes was done based on a conversion 
factor of 13.1 U/mg supplied from the manufacturer. To find the approximate maximum radius 
that particles can grow to without touching each other, referred to as the distance between 
particle centers 〈𝑑〉, the following equations were used: 
〈𝑑〉 = 2𝑅      (39) 
 
where R is the particle radius and 
𝑉 =
4𝜋
3
𝑅3 ∗ 𝑁      (40) 
where N represents number of particles (found by assuming each enzyme seeds one particle) and 
V the solution volume. This estimates the maximum radius before the particles come into contact 
to be ~123 nm. Interestingly, this number is in good agreement with the radius obtained from our 
experimental data (Figure 3-8 (B)) as the size at onset of aggregation lies around 100 nm. These 
findings indicate that the nature of the second process found in DLS is likely an aggregation of 
particles due to crowding. 
 
 
3-2-3). Small Angle Neutron Scattering.  
 
Experimentals. Samples were soaked in either 100% D2O or 100% H2O solvents and 
then filled into quartz banjo cells (Hellma) with path lengths of 2 mm and 1 mm, respectively.  
Concentrations of components in samples were: 0.22 U/ml laccase, 0.22 wt% alginate, and 1.5, 
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15, and 45 mM FeSO4. Once mixed, the particles were allowed to grow undisturbed for 24 hours 
before measurement with SANS.  
Small Angle Neutron Scattering was performed on the system in the semi-dilute regime 
to see if enzymes could still form nanoparticles at higher alginate concentrations. Small angle 
neutron scattering profiles of the alginate gels show measureable structural differences as a 
function of Fe2+ ion concentration, from 1.5 to 15 to 45 mM (see Figure 3-12).  Alginate gel 
samples were prepared and studied in two solvents, 100% H2O and 100% D2O.  A subset of 
alginate gel samples formed with 1.5 and 15 mM of Fe2+ ions were studied in both solvents 
because the use of 100% D2O solvent alleviates two important drawbacks: (1) low scattering 
signal of the sample; and (2) high incoherent backgrounds from hydrogen atoms.  The approach 
to alleviate the first drawback relies on increasing scattering contrast between the sample and 
solvent and the latter by replacing solvent hydrogen atoms with deuterium atoms.  On the other 
hand, the use of 100% D2O potentially introduces detrimental artifacts such as a higher 
propensity for aggregation due to the enhanced activity of the enzyme in this solvent (shown in 
the UV-Vis results, Figure 3-1). Therefore, it is imperative to study representative samples in 
both 100% H2O and 100% D2O solvents to understand the function of solvent identity in particle 
growth. 
To determine the overall particle size and pore size of the nanogels, a graph of I(q) versus 
q was produced by azimuthally averaging the 2d images about the beam center position. The 
resulting curve was fit with the Single level Unified model111 in the IRENA package126 as it was 
the best approach to extract reliable information from the system110:  
𝐼(𝑞) =
[
 
 
 
 
𝐺 ∗ 𝑒𝑥𝑝 (−
𝑞2𝑅𝑔 𝑝𝑎𝑟𝑡
2
3
) + 𝐵 ∗
(
 
 
[erf (
𝑞𝑅𝑔 𝑝𝑜𝑟𝑒
√6
)]
3
𝑞
)
 
 
𝑃
]
 
 
 
 
+ 𝐼𝑏𝑘𝑔  
where G is the scalar for the exponential component, Rg part is the radius of gyration of the 
nanogel particle, Rg pore is the radius of gyration of the nanogel pore, B is the scalar for the power-
law scattering component, P the Porod exponent, and Ibkg is the background intensity with 
incoherent scattering as its predominant component. This model was selected because it fitted the 
intensity profile found for the nanogel particles and produced the most applicable interpretation 
of fitting parameters. It consists of a unified Guinier and Porod model which contains an 
(29) 
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exponential form at lower q, representative of a particle size followed by a power-law profile 
with the Porod exponent reflecting the particle’s bulk properties such as polymer particle 
architecture, conformation, density, shape, and pore size. The results of the fit for all the samples 
are summarized in Table 3-1.   
 
Results: Guinier/Low q Regime. The Guinier component of the Unified model 
primarily fits the experimental data in the low-q regime to provide the radius of gyration of the 
structures. In this region, only the samples in 100% H2O could be fit with the model to find a 
particle size as no exponential component was observed in the 100% D2O samples within the 
studied q range. This trend indicates that larger particles are formed in the 100% D2O solvent 
than in the 100% H2O solvent. In the H2O based samples, particle size, Rg, was found to increase 
with increasing Fe2+ ion concentration.  A 3-fold increase in Fe2+ ion concentration (15 to 45 
mM) resulted in the particle size doubling, Rg increased from ~20 to 40 nm, or an 8-fold increase 
in particle volume if we assume a spherical shape.  The smallest measureable average particle 
size, Rg ~ 20.8 nm, is much larger than the average size of the protein (2.5 nm)
127. This implies 
that free enzyme is not present in the solution and is most likely entangled within the nanogel 
polymer matrix after the growth of the particles is complete. 
 
Results: Porod/High q Regime. The power law profile in the high-q regime provides the 
Porod exponent which gives information on the interior structure of the nanogel particles.  It is 
used to characterize the fractal structure of a gel.109 Shown in Table 3-1, nanogels of all iron 
concentrations exhibited branched structures since their power law exponents fell between 2 and 
3. Porod exponents for other structures such as swollen coils (P = 5/3) and collapsed spheres     
(P = 3) were not observed.107 This branching indicates that the nanogel structure is a porous 
material that is more dense than swollen polymer coils but less dense than hard polymer spheres. 
The variation in Porod exponents demonstrates that the nanogel material has the potential for 
tunable porosity in addition to tunable particle size. 
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Figure (3-12). SANS spectra of alginate gel in solvents: (a) H2O and (b) D2O as a function of 
Fe2+ ion concentration ranging from 1.5 to 45 mM. 
 
 
Table (3-1). Fit parameter values of the single level unified model. 
Buffer Concentration G Rg B P 
 (mM) (cm–1) (Å) (1.0E–5 cm–1)  
H2O 45 19.01 397.2 2.31 2.480 
 15 0.8746 207.7 2.31 2.173 
D2O 15 – – 0.55 2.234 
 1.5 – – 0.04 2.808 
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Figure (3-13). Unified model fitting. Blue lines represent the Guinier fit and green the Porod law. 
In the D2O samples, no Guinier fit could be placed as there was no exponential behavior of the 
samples at low q. 
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CHAPTER 4: DISSCUSION 
 
4-1). Mechanism of Nanogel Growth. 
 
In this thesis, it was hypothesized and proven that nanogels could be synthesized utilizing 
enzyme catalysis to control crosslinking of polymers through ionic charge condensation 
interactions. In our synthesis method we chose to use the enzyme laccase and the polymer 
alginate crosslinked with iron. We showed that the synthesis method is reliant on laccase 
presence as no gelation in solution occurred without it. The growth of the nanogel particles was 
clearly witnessed in the DLS results in Figure 3-8 to give proof that our goal was achieved. The 
kinetics of our nanogel’s growth demonstrate that the enzyme is a key component in the 
synthesis mechanism and that three distinct regions of growth exist in particle formation. To the 
best of our knowledge, the kinetics of nanogel synthesis with an enzyme catalyst has not 
previously been investigated in literature. Understanding the mechanism of nanogel development 
is a key component to establishing control over the particle growth process. This will allow the 
size of nanogel delivery carriers to be tuned appropriately for use in medical applications. 
 
Laccase Catalyzes Particle Growth. It is evident in this synthesis method of alginate 
nanogel particles that the enzyme in the solution serves as a catalyst for particle formation and 
growth. Without the enzyme in the solution, iron oxidation occurs slowly and gelation is only 
witnessed after several weeks of incubation. In solutions with laccase enzyme, gelation was 
shown to occur within several hours given the proper reactant concentrations indicating that a 
catalyst is present to drive the gelation process forward.  
 
Growth Region I. Due to the use of an enzyme catalyst, the growth kinetics of our 
nanogel particles are quite unique. Based on the DLS results in Figure 3-8, it can be seen that 
there are three distinct regions of particle growth. In the first area, Region I, little to no growth of 
the particles is evidenced. One explanation for this occurrence is that intermolecular crosslinking 
between polymer chains has not yet occurred. This may happen because the iron (III) being 
produced by the enzyme is being sequestered through intramolecular crosslinking within 
individual polymer chains. Furthermore, it has been shown from our UV-Vis results that laccase 
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does produce significant amounts of iron (III) early in the growth process. Therefore, the reason 
why no growth is occurring should not be related to the enzyme’s production of iron, but to the 
mechanism of iron crosslinking in solution. Instead we suggest that in region I: all of the 
produced iron is being solely used for intramolecular crosslinking within polymers so that no 
growth of the particles is observed during this time. Another possible explanation for the lack of 
growth in region I may be that the growing particles remain too small to be seen during this 
region as their scattering signal is masked by larger polymer coils in solution. 
 
Growth Region II. In this region fast particle growth was observed. We hypothesized 
that the increase in particle size is due to intermolecular crosslinking between polymer chains. 
Here, as particles grow via assumed attachment/crosslinking of free polymers, the polydispersity 
of the particles rapidly decreases. One reason why the particle size increases may be that the 
amount of iron needed to complete intramolecular crosslinking has been used up and that the 
excess iron (III) produced by the enzyme can now be used to intermolecularly bond polymer 
chains. Furthermore, in region II, polydispersity decreases which presumably indicates that the 
free/unbound alginate polymers (with smaller diameters than the particles) are being taken up by 
the growing particles to create a more homogenous overall particle size distribution in solution.  
It is also assumed that in this step, that enzymes become trapped within the nanogel 
particles as more polymers are added to them. The addition of polymers to the particle should 
hinder enzyme diffusion through the particle matrix. Furthermore, laccase enzymes have been 
shown to exhibit an affinity for iron substrates128 and may very well associate with iron (III) 
crosslinker in the nanogel particles.  
 
Region III. In region III of the growth cycle, there appears a first process in both the 0.36 
mM and 3.6 mM iron samples where growth of the particles levels off and polydispersity 
remains constant. This may be considered the maximum monodisperse particle size that can be 
attained with the given amount of reactants in solution. However, in the 3.6 mM sample, there 
appears a second process in region III. The second process seen is hypothesized to result from 
aggregation of the growing particles. This was confirmed with AFM as images revealed several 
nanogel particles stuck together as the dominant state in this phase. Other clues that support this 
thought are our critical threshold calculations from the results section that calculate similar 
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critical sizes ~123 nm and the suddenness of the onset of the second process which is typical of 
aggregation behavior.129  
 
Overall Growth Kinetics. Putting all of these ideas together offers us a picture of what 
the growth mechanism of our nanogel particles may look like (Figure 4-1). During region I, the 
alginate chains are using iron (III) produced by the enzyme to undergo intramolecular 
crosslinking within themselves. Once all of the intramolecular sites are filled, iron begins 
intermolecularly crosslink with freely diffusing alginate polymers. This signals the beginning of 
region II of the growth process where an increase in particle size and subsequent decrease in 
polydispersity occurs. Polydispersity is seen to decrease because all of the free alginate polymer 
coils are being used up so that less coils are present to broaden the size distribution of the 
solution since they are smaller than the particles. In region III, the growth of the particles levels 
off as all of the iron in the solution is consumed. However, in the case of the sample that 
contained 3.6 mM iron (II), the crosslinker was not used up once the maximum particle size was 
reached. This caused the crowded particles to continue their growth via aggregation. Thus a 
sharp increase in polydispersity arises as particles quickly aggregate due to continued iron 
crosslinker production and crowding.     
 
 
 
Figure (4-1). Proposed mechanism of nanogel particle growth. Shown in (A) is the general 
enzyme catalysis reaction. (B) is a representation of region I and demonstrates intramolecular 
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crosslinking (C) is a representation of region II and shows intermolecular crosslinking between 
several alginate polymers resulting in increasing particle size. (D) represents the particle after 
crosslinking has completed (region III) and before aggregation begins. (E) represents the second 
process in region III, where aggregation of the fully grown nanogel particles occurs.  
 
 
4-2). Tuning Nanogel Particles. 
 
In this work, it was also hypothesized that the nanogel particle kinetics could be easily 
tuned with simple parameters such as environmental conditions and reactant concentrations. We 
effectively showed that size, polydispersity, density, and growth speed of the particles could be 
controlled in this manner. The two environmental parameters we used to alter enzyme activity 
included: oxygen absence and incorporation of deuterated water as a solvent. The synthesis 
components whose concentration was changed to study their effects on nanoparticle growth 
include: alginate, iron, and laccase enzyme.  
 
Oxygen Availability. Oxygen availability was shown to have a significant effect on the 
rate of oxidation of iron (II). Here we demonstrate that laccase activity is diminished when there 
is less oxygen present during synthesis (Figure 3-2). For the enzymatic oxidation of iron (II), 
oxygen gas is a reactant that is believed to receive the electron removed from iron (II) ions. This 
is important because it demonstrates that this parameter may be used to alter the kinetics of 
nanogel growth. In the future, it would be beneficial to know if other environmental conditions 
that affect enzyme activity, such as temperature and pH, may be used to control nanogel particle 
kinetics. This may offer an easy way to terminate nanogel growth in order to dictate the resulting 
size of the grown particles.   
 
Deuterated water. We found that deuterated water also affects particle kinetics by 
slowing iron conversion and increasing resulting particle size. The deceleration of iron (II) 
conversion to iron (III) is shown in the UV-Vis results and the increase in particle size in the 
SANS results. The difference in sizes of particles synthesized in D2O versus H2O most likely 
stems from the higher level of iron (III) produced in deuterated water (Figure 3-1). With more 
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iron present, the attachment of free polymers to the growing particles can be extended. This 
demonstrates the concept that higher concentrations of crosslinker can create larger particles if 
excess polymer is present. Currently, we have no explanation regarding why D2O affects the 
enzyme reaction so drastically. However, we speculate that there are certain enzymatic 
intermediates that may inhibit iron conversion less in heavy water than in normal water.  
 
Alginate Concentration. Controlling the concentration of alginate polymer allowed us to 
create nanogels instead of bulk hydrogels. This can occur because as long as plentiful alginate 
and crosslinker are present, the polymer in solution will continue to crosslink until particle 
crosslinking reaches a scale large enough to be considered bulk gelation. Using ~10 times less 
alginate (0.07 wt% instead of 0.67 wt%) in solution allowed the formation of nanogel particles as 
opposed to bulk hydrogels. It is well known that formation of nanoparticles is favored in dilute 
solutions.130 Interestingly, our particles still formed while in the semi-dilute regime in the SANS 
experiments. This is most likely due to the enzymatic nature of our synthesis scheme. Even in 
bulk gels, it is known that enzyme catalyzed gel formation creates certain local areas of more 
densely crosslinked polymers.131 One reason this may happen is because enzymes can create 
uneven distributions of crosslinker in solution. This results from the restriction of their 
movement due to entrapment in the growing polymer matrix during the growth process. When 
the enzymes are confined within crosslinking polymers, the iron concentration near that area 
naturally increases as the enzyme continues to produce crosslinker. This may be a factor that 
drives nanogel formation even in a semi-dilute polymer solution.   
 
Iron Concentration. The amount of iron in the solution was shown to affect nanogel 
speed of growth, size, density, and aggregation. The first outcome of increased iron 
concentration was an increase in the speed of nanoparticle formation. We believe that the speed 
of the reaction increases with higher iron concentrations because there is more iron (III) present 
in solution. The speed of the laccase enzyme reaction does not limit the oxidation of iron. 
Otherwise, increasing the iron (II) concentration would have no effect on the resulting iron (III) 
presence. This would cause amounts of iron (III) to remain the same no matter how much iron 
(II) is added to the solution. However, it seems that in our system, diffusion to the enzyme active 
site is what limits the amount of iron (III) produced as amounts can be increased upon iron (II) 
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addition. This is evidenced in Figure 3-8 when the 0.36 mM iron (II) sample reaches it maximum 
particle size at ~3000 minutes, and the 3.6 mM iron (II) reaches its peak size at ~300 minutes. 
Secondly, size of the nanogels can be controlled with iron concentration. Polymers attach 
to the nanoparticle via crosslinking, so if the amount of crosslinker is increased, then attachment 
is increased, and the particle size is increased (seen in the DLS results). However, growth of 
particle size due to iron concentration can only occur when excess polymer is present. Without 
extra polymer, the particles will only aggregate when extra iron is introduced as there is nothing 
more left to crosslink in the solution besides the particles themselves.  
Thirdly, the density of the interior structure of the nanogels was controlled by iron 
concentration. This can be seen in the SANS results where the Porod exponent fluctuates with 
iron variation. Currently, we have no explanation or suppositions regarding this density change. 
However it is significant and should be noted that this parameter can be controlled through iron 
concentration. 
Lastly, iron concentration controls the onset of aggregation in nanogel particle growth. 
This is seen in the DLS results when the sample with 0.36 mM iron shows no aggregation, but 
the 3.6 mM does. Aggregation may occur for two reasons. 1). because the particles become too 
crowded in the solution to continue growing and begin to link with one another and 2). because 
the free polymer has been used up so that iron crosslinker begins to bind particles together 
instead. In the first scenario, particles may form aggregates because the solution reaches a critical 
threshold where there is no more room for growth and thus the particles must bind to one another 
to continue the growth process with iron crosslinker. In the second scenario, aggregation occurs 
because the polymer concentration is limited so that excess iron crosslinker begins to bind 
particles together instead of free polymer. Understanding where this critical aggregation 
threshold lies will be important to the creation of precise sizes of nanogel particles with this 
synthesis method in the future.  
 
Enzyme Concentration. We found that laccase concentration affects the speed of iron 
conversion from the UV-Vis results and likely the size of the nanogel particles in solution. 
Although we did not collect data to see if a relationship between increasing enzyme 
concentration and particle size exists, literature supports this hypothesis. In a recent paper by 
Silva et al., the authors synthesized bulk hydrogels crosslinked by enzyme catalysis and studied 
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them with SANS. They showed that their gel was inhomogenous due to enzyme presence and 
exhibited clusters of densely crosslinked regions that were attributed to enzyme activity. 
Furthermore, they showed that as the amount of enzyme increased in a sample, the size of these 
dense clusters correspondingly increased.131 Therefore, we assume that our particles will act in a 
similar manner where increasing enzyme concentration leads to larger particle sizes. 
 
Summary. Overall it can be seen from the results presented in this work that altering 
concentrations of synthesis components can have a drastic effect on nanogel formation kinetics. 
The enzymatic nature of our synthesis scheme allows the size, polydispersity, density, and speed 
of nanogel particle formation to be easily regulated. A summary of how specific synthesis 
components change the growth kinetics of nanogel particles is listed in Table 4-1. Furthermore, 
additional control over the reaction can be exerted using environmental parameters, such as 
oxygen availability and solvent type, making this method finely tunable to the needs of specific 
medical applications. 
 
 
Table (4-1). Effects of component concentrations on the growth of nanogel particles when they 
are limiting (+) and in excess (-) based on their discussion in chapter 4. 
Component Limiting Reagent Limiting Reagent Limiting Reagent 
Laccase + - - 
Alginate - + - 
Iron - - + 
Controlled 
Properties 
1). Size of particles 1). Dictates whether 
gel or nanoparticles 
 
2). Size of particles  
1). Speed of particle 
growth  
 
2). Propensity for 
aggregation.  
 
3). Density of gel particle 
matrix 
 
4). When < aggregation 
size, controls particle size 
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4-3) Assessment of Drug Delivery Capability. 
 
The experiments and results demonstrated here show how the nanogel growth reaction 
can be controlled with synthesis conditions and components to create monodisperse drug 
delivery particles for future biomedical applications. The nanogels synthesized in this thesis are 
good delivery systems for biotherapeutics because they can be grown to sizes below 100 nm, 
allow for simple size tunability, and have a low size distribution. Furthermore, they meet other 
requirements for successful drug delivery devices such as: utilization of 
biodegradable/biocompatible materials, lack of toxic synthesis components, simple synthesis, 
and inexpensive materials.  
From the dynamic light scattering results, we demonstrate that particles can be grown to 
45 nm within 3000 minutes and 100 nm within 300 minutes using two different concentrations of 
iron sulfate. Additionally, the polydispersity of sizes can be forced to remain low by limiting iron 
(II) availability in solution. We also showed that oxygen presence (another enzyme reactant) 
influences enzyme activity which leads us to believe that nanogel sizes may be affected by this 
parameter and others that adjust enzyme reaction speed, such as temperature and pH. Another 
important finding from our experiments was that the limit at which aggregation occurred (for 
solutions containing 0.187 U/ml enzyme and 0.07 wt% polymer) lies somewhere between 
concentrations of 0.36 and 3.6 mM iron.  
In the future, finding at what concentration the aggregation limit occurs will enable the 
accurate synthesis of particles with low polydispersity for increased drug delivery efficiency. 
Also, another factor that should be explored in future studies is how to improve the mechanical 
strength of these nanogels. Typically, charge condensated materials rapidly dissolve in aqueous 
environments. This causes them to release encapsulated drugs quickly. For extended drug release 
and targeting applications, these particles might be modified with protective coatings for future 
biomedical applications.  
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CHAPTER 5: CONCLUSIONS 
 
Here we demonstrate the synthesis and characterization of enzyme catalyzed nanogel 
particle formation. Using laccase enzymes, alginate polymers, and iron (II) sulfate purchased 
commercially, the synthesis can be carried out in one pot, one step, and completed in a single 
day. In this thesis, the focus of our experimentation was to see how concentrations of synthesis 
components and environmental conditions can be altered to tune the size and polydispersity of 
nanogel particles. 
One of the components that was used to control nanogel size and polydispersity was the 
concentration of iron (II) in solution. Nanogels made with different iron concentrations were 
characterized extensively with several techniques. Dynamic light scattering was used to capture 
the growth kinetics of the particles in real time. It was found that their size and polydispersity 
varied depending on the stage of growth in which the particles existed. Furthermore, once the 
particles grew to their maximum size, their polydispersity remained low when aggregation was 
not present. Atomic Force Microscopy was used to image the particles during the growth cycle to 
verify the DLS results. They revealed corresponding particle sizes and aggregates as 
confirmation. Small Angle Neutron Scattering was used to determine how size and 
density/porosity of the particles changes with iron concentration in the semi-dilute region. It was 
found that the size of the particles in water was similar to DLS, but not in D2O as the particles 
were significantly larger. Density of the internal particle structure was also shown to change with 
iron concentration and solvent type. Lastly, UV-Visible spectroscopy revealed that the laccase 
enzyme is the catalyst that drives nanogel formation. The appearance of iron (III) and 
disappearance of iron (II) were significantly enhanced due to enzyme activity and were found to 
be affected by oxygen and D2O presence.  
Our results show that this method of enzyme catalyzed nanogel synthesis offers 
considerable control over nanogel particle growth kinetics. By changing conditions such as iron 
(II) concentration, oxygen concentration, and D2O presence, the size, growth speed, density, and 
polydispersity of the particles may be regulated. This supplies the experimentalist with many 
tools that are easy to use in order to control the size of these nanogel particles.  
In summary, this thesis has divulged a method with which to grow nanogel particles with 
tunable sizes below 100 nm using enzymatic catalysis. To the best of our knowledge, this 
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investigation documents the first account by which nanogel particles cross-linked via enzyme 
activity have been achieved without previous polymer modification.132 These particles are good 
candidates for drug delivery carriers as they have low polydispersity, sizes below 100 nm, and 
are synthesized with a simple one-step method. Furthermore, application of these materials to the 
biomedical profession is facilitated by the use of biocompatible and inexpensive materials, 
solvents, and reactants. 
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